Role of Prokineticin in Epicardial Progenitor Cell Differentiation to Regenerate Heart

1. Introduction

Cardiovascular diseases are one of the most common health-care problems throughout the world and carry a high rate of mortality (Zannad, et al., 2009). New strategies are urgently needed to replace cardiomyocytes and increase circulatory support for the treatment of cardiovascular diseases.

Over the last decade, stem/progenitor-cell therapy has emerged as an innovative approach to provide cardiac repair and regeneration(Zimmermann, et al., 2006). Several stem- and progenitor-cell types from autologous and allogeneic donors have been analyzed to find the most appropriate candidate. Although embryonic stem (ES) cells can differentiate into most cardiac cell types(Mummery, et al., 2002), their clinical use is severely limited due to ethical concerns and immunogenic and teratogenic side effects (Blum and Benvenisty, 2008). Adult bone marrow-derived stem cells avoid the ethical and clinical issues associated with ES cells (Bianco, et al., 2001). However, animal studies have demonstrated a variable degree of cardiomyogenesis, and improvement in heart function by bone marrow-derived stem cells(Murry, et al., 2004). Thus, the utility of adult bone marrow-derived stem cells is hampered by their limited population size and restricted potential for cardiovascular differentiation (Assmus, et al., 2010).

Recently, therapies based on cardiac progenitor cells (CPC) have emerged as promising potential cardiac therapeutics(Gonzales and Pedrazzini, 2009). For cardiovascular therapy, pluripotent cardiac progenitor cells (CPCs) resident in the epicardium offer distinct advantages over other adult stem-cell types(Wessels and Perez-Pomares, 2004). They are autologous, tissue-specific and pre-committed (Dube, et al., 2012) to a cardiac fate, and display a greater propensity to differentiate towards cardiovascular lineages(Cai, et al., 2008), (Smart and Riley, 2012). Epicardial derived cardiac progenitor cells (EPDCs) exist in the heart of several species, including mice (Limana, et al., 2007) and humans (van Tuyn, et al., 2007). Due to cardiogenic and angiogenic abilities, epicardial CPCs represent an ideal candidate for cardiac regeneration. However, we do not know the mechanisms underlying epicardial CPC self renewal, proliferation and differentiation, which are prerequisites for cardiac regenerative therapy. An optimal paradigm of cardiovascular therapy may therefore consist of identifying the most effective factors that trigger the restoration of epicardial CPCs for healing heart injuries, with an emphasis on small molecule-based therapy over cell-based therapy.

It is therefore imperative to obtain a better understanding of the biology and regenerative potential of endogenous epicardial CPCs. The race is still on to find the “best” factor or drugs to reprogram endogenous epicardial CPCs to reconstitute the myocardium and improve function after myocardial damage.

2. Epicardium as a source of multipotent progenitor cells

Epicardium derived from proepicardium has an essential modulating role in the differentiation of the compact ventricular layer of the myocardium and the development of cardiac vessels during embryogenesis(Zhou, et al., 2008). Deletions of selected genes expressed in the epicardium (i.e. VCAM-1, α4-integrin) resulted in severe defects in the developing heart and its vasculature.The zebrafish epicardium promotes cardiac regeneration through epithelial to mesenchymal transition (EMT) and subsequent migration into the myocardium to form neovasculorization (Lepilina, et al., 2006).Signalling from the myocardium to the epicardium (i.e. Tβ4, FOG-2) (Smart, et al., 2007; Tevosian, et al., 2000) also leads undeveloped ventricle with vascularisation defects.

The epicardium through EMT generates a population of Epicardial Derived Progenitor Cells (EPDCs) that invade the underlying myocardium, and differentiate into various cardiac lineages (Smart and Riley, 2012; Zhou, et al., 2008). Williams Tumour (WT1) gene has been shown to regulate epicardial EMT through beta-catenin (Zamora, et al., 2007) and retinoic acid signaling pathways (von Gise, et al., 2011). EPDCs can either form endothelial cells, in response to a combination of myocardial vascular endothelial growth factor and basic-fibroblast growth factor signalling (van Wijk, et al., 2009), or differentiate into smooth muscle cells, upon exposure to platelet-derived growth factor (Kang, et al., 2008), transforming growth factor beta and bone morphogenetic protein-2 (Sanchez and Barnett, 2012).

However, Tβ4(Smart, et al., 2007) and PKR1 (Urayama, et al., 2008) signaling appear to be a necessary and sufficient signaling factor for adult EPDC differentiation into the endothelial and smooth muscle cells to induce neovascularization. Thymosin beta-4 can activate adult epicardial cells (Bock-Marquette, et al., 2009) acting through reactivation of embryonic signalling pathways (Smart, et al., 2007).

In a regenerative context, the adult epicardial progenitor cell population also mediates cardiac repair after injury. Tβ4can activate adult epicardial cells (Bock-Marquette, et al., 2009; Smart, et al., 2007) to promote revascularization of the injured mammalian heart by forming endothelial and vascular smooth muscle cells. Tβ4treatment before myocardialinfarction alters the responsiveness and fate ofactivated epicardial cells (WT1+ progenitor cells), to differentiate into cardiomyocytes (Smart, et al., 2011). However Tβ4 treatment after myocardial infarction induces epicardial expansion and coronary capillary density without affecting migration or alteration of WT1⁺ progenitor cell fate into cardiomyocytes (Zhou, et al., 2012). Tβ4 treatment of mice after MI activates cardiac progenitor cell fate to induce cardiomyocyte linage (Bock-Marquette, et al., 2009). However, the cardiac progenitor subpopulation remains to be characterized. Further, a sub-population of adult epicardial cells retains the potential to give rise to cardiac precursors or endothelial cells (Limana, et al., 2007). The regenerative potential of EPDCs has been tested in the injured myocardium. The injection of human EPDCs was reported to enhance cardiac repair (Winter, et al., 2007). When the cardiomyocyte progenitors were co-transplanted with EPDCs into infarcted myocardial tissues, they improved functional repair as compare to single cell type supplementation (Zhou, et al., 2011). The effect was shown to be caused by paracrine effects from both cell types. Nevertheless, signals and cellularcontributions from the EPDCs are indispensable for the establishment of normal coronary vasculatureand myocardial architecture(Smart and Riley, 2012; Winter, et al., 2009).

3. GPCRs and cardiovascular system

Many hormones and neurotransmitters use GPCRs to exert their cardiovascular effects (Marinissen and Gutkind, 2001; Tang and Insel, 2004). Relatively little information is available regarding the role of GPCRs in the functional activities of cardiac stem/progenitor cells, both in normal and disease conditions. The well-studied cardiac role of GPCRs via Gαq signalling (Gutkind and Offermanns, 2009) is to promote cardiac hypertrophy (Wettschureck, et al., 2001)or protect cardiomyocytes against hypoxic insult(Nebigil, et al., 2003). Gα12 signaling can interact with the cytoplasmic domain of cadherins (Kaplan, et al., 2001), resulting in the release of the transcriptional activator β-catenin. Gα13 signaling is involved in vessel formation (Offermanns, et al., 1997). Gαs signaling regulates heart rate and contractility in response to catecholamine stimulation, but excessive Gαs signaling in heart eventually induces myocardial hypertrophy, fibrosis and necrosis (Gaudin, et al., 1995). Given the important roles of GPCRs in cardiac regulation, a key question is how many different GPCRs exist in the heart and what is their physiologic significance? Since forty percent of these GPCRs represent viable drug targets (Schlyer and Horuk, 2006) and also many of GPCR is involved in regulating cardiovascular system, unraveling of novel GPCR in cardiac progenitor/stem cells is very important to develop novel therapies for limit cardiovascular disease.

3.1. Prokineticins and cognate receptors

Prokineticins are structurally homologues of amphibian or reptilian peptide toxins(Kaser, et al., 2003). They were first identified in the gastrointestinal tract as potent agents mediating muscle contraction(Hoogerwerf, 2006; Li, et al., 2001), and have been isolated from bovine milk (Masuda, et al., 2002). They comprise two classes: Prokineticin-1 (PK1), originally called endocrine gland-derived vascular endothelial growth factor (EG-VEGF) (LeCouter and Ferrara, 2002) based on the functional similarity to VEGF andprokineticin-2 (PK2, also called Bv8). PK1 and PK2 are approximately 50% homologous and contain carboxyl-terminal cysteine-rich domains that form five disulfide bridges(Bullock, et al., 2004). N terminal hexapeptide (AVITGA) and cysteine residues in the carboxy-terminal domain are crucial for their biological activities. Prokineticins and their receptor are widely distributed in mammalian tissues(Soga, et al., 2002). Prokineticins inducecell excitability such as gut spasmogen (Wade, et al., 2009), pain sensitization(Negri, et al., 2006), circadian rhythm(Li, et al., 2006), and sleep(Hu, et al., 2007)). They also induce cell motility such as angiogenesis(LeCouter and Ferrara, 2002), neurogenesis (Ng, et al., 2005), hemotopoiesis (LeCouter, et al., 2004), neovasculogenesis(Urayama, et al., 2008). Prokineticins regulate complex behaviors such as feeding(Negri, et al., 2004), drinking(Negri, et al., 2004), anxiolity (Li, et al., 2009). Moreover, prokineticins are potent survival/mitogenic factors for various cells including endothelial cells , neuronal cells (Kisliouk, et al., 2005; Ngan, et al., 2007a), lymphocytes, hematopoietic stem cells(LeCouter, et al., 2004), and cardiomyocytes (Nebigil, 2009). Table 1 summarize the involvement of prokineticin in the diseases.

Prokineticins bind to two cognate 7-transmembrane G-protein-coupled receptors. PKR1 and PKR2 share about 85% amino acid identity and encoded within distinct chromosomes in both mouse and human (Masuda, et al., 2002). Prokineticin-2 is the most potent agonist for both receptors (Masuda, et al., 2002). PKR2 is the dominant receptor in the adult brain, particularly in the hypothalamus, the olfactory ventricular regions, and the limbic system. However, PKR1 is widely distributed in the periphery. These receptors couple to Gαq, Gαi and Gαs to mediate intracellular calcium mobilization, activation of MAPK, Akt kinases and cAMP accumulation, respectively (Ngan and Tam, 2008). Although prokineticin signaling has been implicated as a survival/mitogenic factor for various cells including endothelial cells (Guilini, et al., 2010), neuronal cells (Ngan, et al., 2007b), enteric neural crest cells (Ngan, et al., 2007a), granulocytic (Giannini, et al., 2009)and monocytic lineage(Dorsch, et al., 2005), lymphocytes and hematopoietic stem cells (LeCouter, et al., 2004), until recently, little was known about the underlying molecular and cellular events to regulate cardiovascular function.

3.1.1. A novel role for prokineticin in regulating cardiovascular system

PK2/PKR1 signaling pathway seems an important cardiovascular regulatory pathway, because of the following aspects: Prokineticins are potent angiogenic factors (LeCouter and Ferrara, 2003), which have beneficial effects on cardiac repair by inducing angiogenesis to improve coronary circulation or regenerating the cardiomyocytes (Bellomo, et al., 2000). They exert their biological effects via activating GPCRs that couple to diverse G proteins. Mutations in the gene encoding prokineticin-2 cause Kallmann syndrome (hypogonadotropic hypogonadism) in human (Abreu, et al., 2008; Canto, et al., 2009; Cole, et al., 2008), with congestive heart failure and dilated cardiomyopathy. Prokineticins induce differentiation of murine and human bone marrow cells into the monocyte/macrophage lineage and activate monocyte proliferation, differentiation and macrophage migration (Denison, et al., 2008; Dorsch, et al., 2005; Giannini, et al., 2009). In human end-stage failing heart samples, reduced PKR1 and prokineticin-2 transcripts and protein levels implicate a more important role for PK2/PKR1 signaling in heart (Urayama, et al., 2007). Therefore, we reasoned that PK2/PKR1 signaling should contribute to heart repair by inducing angiogenesis or repairing cardiomyocytes.

3.1.2. Role of PKR1 signaling in cardiovascular system

In cultured capillary endothelial cells derived from heart, PK2 via PKR1 induces proliferation, migration and vessel-like formation, activating Gα11/MAPK and Akt kinases (Guilini, et al., 2010). In cardiomyocytes, activation of overexpression of PKR1 protects cardiomyocytes against hypoxic insult, activating the PI3/Akt pathway (Urayama, et al., 2007).

Transient PKR1 gene transfer after coronary ligation in the mouse model of myocardial infarction reduces mortality and preserves heart function by promoting cardiac angiogenesis and cardiomyocyte survival. This result suggests that PKR1 may represent a novel therapeutic target to limit myocardial injury following ischemic events (Urayama, et al., 2007).

Transgenic mice overexpressing PKR1 specifically in the heart under the control of cardiac α-myosin heavy chain (α-MHC) promoter displayed no spontaneous abnormalities of cardiomyocytes, but showed increased neovascularisation (Urayama, et al., 2008). Thus, these data suggest that PKR1 is involved in post-natal de novo vascularization, rather than vasculogenesis during embryogenesis.

Genetic inactivation of PKR1 in mice (PKR1-knockout mice) exhibit dilated cardiomyopathy and reduced angiogenesis in heart(Boulberdaa, et al., 2011). The heart pathology in PKR1 knockout mice is due to increased apoptosis in cardiomyocytes and reduced epicardial progenitor cell numbers. These data was consistent with an endogenous role of PKR1 signalling in stimulating epicardial progenitor cell proliferation and differentiation. All together these findings show that PKR1 signalling is involved in regulating cardiomyocytesurvival signalling, and progenitor cell proliferation and differentiation.

3.1.3. Role of PKR2 signaling in cardiovascular system

Since PKR1 and PKR2 are 85% identical and are both expressed in cardiovascular tissues, PKR2 may also contribute to cardiomyocyte growth and vascularization. Transgenic mice overexpressing PKR2 specifically in the heart under the control of cardiac (α-MHC) promoterexhibit eccentric hypertrophy in an autocrine regulation and impaired endothelial integrity in a paracrine regulation without inducing angiogenesis (Urayama, et al., 2009). These transgenic PKR2 mice may provide a new genetic model for heart diseases. We found that in the endothelial cells PKR2 couples to Gα12 signaling pathway and downregulates ZO-1, thereby inducing endothelial cell fenestration (Urayama, et al., 2009).

3.1.4. Prokineticin signaling in cardiac stem/progenitor cell activation

Prokineticin-2 has been shown to modulate mobilization of bone morrow-derived cells and also promote angiogenesis. Systemic exposure to prokineticins promoted the survival of hematopoietic cells and enhanced progenitor mobilization (LeCouter, et al., 2004). Recently, we found that prokineticin-2 induces significant outgrowth from mouse epicardial explants and quiescent EPDCs, restoring epicardial pluripotency and triggering differentiation of endothelial and vascular smooth muscle cells (Urayama, et al., 2008). Co-culturing EPDCs with cardiomyocytes overexpressing PKR1 increased prokineticin-2 levels as a paracrine factor, thereby promoting EPDC differentiation, mimicking our PKR1-transgenic mice model (Urayama, et al., 2008). These prokineticin-2 effects were abolished in EPDC derived from PKR1-null mutant hearts, demonstrating PKR1 involvement. Prokineticin/PKR1 signaling can reprogram adult EPDCs to induce neovascularization. These studies provided novel insight for possible therapeutic strategies aiming at restoring pluripotency of adult EPDCs to promote neovasculogenesis, by induction of cardiomyocyte- PKR1 signaling. Whether epicardial-PKR1 signaling contributes cardiomyocyte function and metabolism, and it determines lineage choice decision in EPDCs remained to be investigated.

Figure 1.

Role of prokineticin PKR1 signaling in cardiac regeneration.

PKR1 signaling protects cardiomyocyte against hypoxia-mediated apoptosis, activates endothelial cells for angiogenesis, activates EPDC differentiation into vasculogenic cell type to induce neovascular formation, activates EPDC differentiation into new cardiomyocytes.

DOMAIN	ROLE/EXPRESSION in human organs	REFERENCE
Reproduction
Menstrual cycle	Progesterone induces elevation of prokineticin-1 expression during the secretory phase indicating a role of prokineticins and their receptors in endometrial vascular function	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXR0ZXJzYnk8L0F1dGhvcj48WWVhcj4yMDA0PC9ZZWFy PjxSZWNOdW0+MjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inc5ZDJ3c2U1MHZkMGVsZTJlczl2MDV6NnN0 MjBmcjV3ZnBkdCI+Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmF0 dGVyc2J5LCBTLjwvYXV0aG9yPjxhdXRob3I+Q3JpdGNobGV5LCBILiBPLjwvYXV0aG9yPjxhdXRo b3I+TW9yZ2FuLCBLLjwvYXV0aG9yPjxhdXRob3I+TWlsbGFyLCBSLiBQLjwvYXV0aG9yPjxhdXRo b3I+SmFiYm91ciwgSC4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt YWRkcmVzcz5EZXBhcnRtZW50IG9mIFJlcHJvZHVjdGl2ZSBhbmQgRGV2ZWxvcG1lbnRhbCBTY2ll bmNlcywgQ2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgVW5pdmVyc2l0eSBvZiBFZGlu YnVyZ2gsIEVkaW5idXJnaCBFSDE2IDRTQiwgVW5pdGVkIEtpbmdkb20uPC9hdXRoLWFkZHJlc3M+ PHRpdGxlcz48dGl0bGU+RXhwcmVzc2lvbiBhbmQgcmVndWxhdGlvbiBvZiB0aGUgcHJva2luZXRp Y2lucyAoZW5kb2NyaW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3Ro IGZhY3RvciBhbmQgQnY4KSBhbmQgdGhlaXIgcmVjZXB0b3JzIGluIHRoZSBodW1hbiBlbmRvbWV0 cml1bSBhY3Jvc3MgdGhlIG1lbnN0cnVhbCBjeWNsZTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K IENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp Y2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjwvcGVy aW9kaWNhbD48cGFnZXM+MjQ2My05PC9wYWdlcz48dm9sdW1lPjg5PC92b2x1bWU+PG51bWJlcj41 PC9udW1iZXI+PGVkaXRpb24+MjAwNC8wNS8wNjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+ RW5kb21ldHJpdW0vY3l0b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxl PC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxpY3VsYXIgUGhhc2UvcGh5c2lvbG9neTwva2V5d29yZD48 a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxr ZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5MdXRlYWwgUGhhc2UvcGh5c2lvbG9neTwv a2V5d29yZD48a2V5d29yZD5NZW5zdHJ1YWwgQ3ljbGUvKnBoeXNpb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+TXlvbWV0cml1bS9jeXRvbG9neS9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPk5l dXJvcGVwdGlkZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ2VzdGVyb25lL3Bo YXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVk LyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgUGVwdGlkZS8qbWV0YWJv bGlzbTwva2V5d29yZD48a2V5d29yZD5SZXZlcnNlIFRyYW5zY3JpcHRhc2UgUG9seW1lcmFzZSBD aGFpbiBSZWFjdGlvbjwva2V5d29yZD48a2V5d29yZD5UaXNzdWUgRGlzdHJpYnV0aW9uPC9rZXl3 b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3IsIEVuZG9jcmlu ZS1HbGFuZC1EZXJpdmVkLyptZXRhYm9saXNtPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5 ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9k YXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNi bj48YWNjZXNzaW9uLW51bT4xNTEyNjU3ODwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11 cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2Nt ZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9 MTUxMjY1Nzg8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGxhbmd1YWdlPmVuZzwvbGFuZ3Vh Z2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CYXR0ZXJzYnk8L0F1dGhvcj48WWVhcj4yMDA0PC9ZZWFy PjxSZWNOdW0+MjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MjwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Inc5ZDJ3c2U1MHZkMGVsZTJlczl2MDV6NnN0 MjBmcjV3ZnBkdCI+Mjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFs IEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+QmF0 dGVyc2J5LCBTLjwvYXV0aG9yPjxhdXRob3I+Q3JpdGNobGV5LCBILiBPLjwvYXV0aG9yPjxhdXRo b3I+TW9yZ2FuLCBLLjwvYXV0aG9yPjxhdXRob3I+TWlsbGFyLCBSLiBQLjwvYXV0aG9yPjxhdXRo b3I+SmFiYm91ciwgSC4gTi48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt YWRkcmVzcz5EZXBhcnRtZW50IG9mIFJlcHJvZHVjdGl2ZSBhbmQgRGV2ZWxvcG1lbnRhbCBTY2ll bmNlcywgQ2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgVW5pdmVyc2l0eSBvZiBFZGlu YnVyZ2gsIEVkaW5idXJnaCBFSDE2IDRTQiwgVW5pdGVkIEtpbmdkb20uPC9hdXRoLWFkZHJlc3M+ PHRpdGxlcz48dGl0bGU+RXhwcmVzc2lvbiBhbmQgcmVndWxhdGlvbiBvZiB0aGUgcHJva2luZXRp Y2lucyAoZW5kb2NyaW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3Ro IGZhY3RvciBhbmQgQnY4KSBhbmQgdGhlaXIgcmVjZXB0b3JzIGluIHRoZSBodW1hbiBlbmRvbWV0 cml1bSBhY3Jvc3MgdGhlIG1lbnN0cnVhbCBjeWNsZTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5K IENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2Rp Y2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFiPC9mdWxsLXRpdGxlPjwvcGVy aW9kaWNhbD48cGFnZXM+MjQ2My05PC9wYWdlcz48dm9sdW1lPjg5PC92b2x1bWU+PG51bWJlcj41 PC9udW1iZXI+PGVkaXRpb24+MjAwNC8wNS8wNjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+ RW5kb21ldHJpdW0vY3l0b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+RmVtYWxl PC9rZXl3b3JkPjxrZXl3b3JkPkZvbGxpY3VsYXIgUGhhc2UvcGh5c2lvbG9neTwva2V5d29yZD48 a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxr ZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5MdXRlYWwgUGhhc2UvcGh5c2lvbG9neTwv a2V5d29yZD48a2V5d29yZD5NZW5zdHJ1YWwgQ3ljbGUvKnBoeXNpb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+TXlvbWV0cml1bS9jeXRvbG9neS9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPk5l dXJvcGVwdGlkZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ2VzdGVyb25lL3Bo YXJtYWNvbG9neTwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVk LyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgUGVwdGlkZS8qbWV0YWJv bGlzbTwva2V5d29yZD48a2V5d29yZD5SZXZlcnNlIFRyYW5zY3JpcHRhc2UgUG9seW1lcmFzZSBD aGFpbiBSZWFjdGlvbjwva2V5d29yZD48a2V5d29yZD5UaXNzdWUgRGlzdHJpYnV0aW9uPC9rZXl3 b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3IsIEVuZG9jcmlu ZS1HbGFuZC1EZXJpdmVkLyptZXRhYm9saXNtPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5 ZWFyPjIwMDQ8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5NYXk8L2RhdGU+PC9wdWItZGF0ZXM+PC9k YXRlcz48aXNibj4wMDIxLTk3MlggKFByaW50KSYjeEQ7MDAyMS05NzJYIChMaW5raW5nKTwvaXNi bj48YWNjZXNzaW9uLW51bT4xNTEyNjU3ODwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11 cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2Nt ZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9 MTUxMjY1Nzg8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGxhbmd1YWdlPmVuZzwvbGFuZ3Vh Z2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A ADDIN EN.CITE.DATA (Battersby, et al., 2004)
	Prokineticin-1 is derived from granulosa lutein cells and its synthesis is elevated during the mid- to late luteal phase	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFyPjxS ZWNOdW0+MTY5PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNjk8L3JlYy1udW1iZXI+PGZv cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1OTJwMnhhOTd6NXRlOGVmcDlicGZ4dDN4 ZGVydGF4dmRmMnQiPjE2OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+ RnJhc2VyLCBILiBNLjwvYXV0aG9yPjxhdXRob3I+QmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPldp bHNvbiwgSC48L2F1dGhvcj48YXV0aG9yPlRheWxvciwgUC4gRC48L2F1dGhvcj48YXV0aG9yPk1v cmdhbiwgSy48L2F1dGhvcj48YXV0aG9yPkFuZGVyc29uLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+ RHVuY2FuLCBXLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy ZXNzPk1lZGljYWwgUmVzZWFyY2ggQ291bmNpbCBIdW1hbiBSZXByb2R1Y3RpdmUgU2NpZW5jZXMg VW5pdCwgQ2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgRWRpbmJ1cmdoLCBTY290bGFu ZCwgVW5pdGVkIEtpbmdkb20uIGguZnJhc2VyQGhyc3UubXJjLmFjLnVrPC9hdXRoLWFkZHJlc3M+ PHRpdGxlcz48dGl0bGU+TG9jYWxpemF0aW9uIGFuZCBxdWFudGlmaWNhdGlvbiBvZiBjeWNsaWMg Y2hhbmdlcyBpbiB0aGUgZXhwcmVzc2lvbiBvZiBlbmRvY3JpbmUgZ2xhbmQgdmFzY3VsYXIgZW5k b3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciBpbiB0aGUgaHVtYW4gY29ycHVzIGx1dGV1bTwvdGl0bGU+ PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxl PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFi PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDI3LTM0PC9wYWdlcz48dm9sdW1lPjkw PC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGVkaXRpb24+MjAwNC8xMC8xNjwvZWRpdGlvbj48 a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q29ycHVzIEx1dGV1bS8q bWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVt YW5zPC9rZXl3b3JkPjxrZXl3b3JkPkltbXVub2hpc3RvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3 b3JkPkluIFNpdHUgSHlicmlkaXphdGlvbjwva2V5d29yZD48a2V5d29yZD5MdXRlYWwgUGhhc2U8 L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ2VzdGVy b25lL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSwgTWVzc2VuZ2VyL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJhbnNjcmlwdGFzZSBQb2x5bWVyYXNlIENoYWluIFJlYWN0 aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3Ig QS9hbmFseXNpcy8qZ2VuZXRpY3MvcGh5c2lvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRl cz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVz PjwvZGF0ZXM+PGlzYm4+MDAyMS05NzJYIChQcmludCkmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8 L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTU0ODMwOTM8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0 ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNn aT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91 aWRzPTE1NDgzMDkzPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291 cmNlLW51bT5qYy4yMDA0LTA4NDMgW3BpaV0mI3hEOzEwLjEyMTAvamMuMjAwNC0wODQzPC9lbGVj dHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np dGU+PC9FbmROb3RlPgB= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GcmFzZXI8L0F1dGhvcj48WWVhcj4yMDA1PC9ZZWFyPjxS ZWNOdW0+MTY5PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xNjk8L3JlYy1udW1iZXI+PGZv cmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1OTJwMnhhOTd6NXRlOGVmcDlicGZ4dDN4 ZGVydGF4dmRmMnQiPjE2OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3Vy bmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+ RnJhc2VyLCBILiBNLjwvYXV0aG9yPjxhdXRob3I+QmVsbCwgSi48L2F1dGhvcj48YXV0aG9yPldp bHNvbiwgSC48L2F1dGhvcj48YXV0aG9yPlRheWxvciwgUC4gRC48L2F1dGhvcj48YXV0aG9yPk1v cmdhbiwgSy48L2F1dGhvcj48YXV0aG9yPkFuZGVyc29uLCBSLiBBLjwvYXV0aG9yPjxhdXRob3I+ RHVuY2FuLCBXLiBDLjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRy ZXNzPk1lZGljYWwgUmVzZWFyY2ggQ291bmNpbCBIdW1hbiBSZXByb2R1Y3RpdmUgU2NpZW5jZXMg VW5pdCwgQ2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgRWRpbmJ1cmdoLCBTY290bGFu ZCwgVW5pdGVkIEtpbmdkb20uIGguZnJhc2VyQGhyc3UubXJjLmFjLnVrPC9hdXRoLWFkZHJlc3M+ PHRpdGxlcz48dGl0bGU+TG9jYWxpemF0aW9uIGFuZCBxdWFudGlmaWNhdGlvbiBvZiBjeWNsaWMg Y2hhbmdlcyBpbiB0aGUgZXhwcmVzc2lvbiBvZiBlbmRvY3JpbmUgZ2xhbmQgdmFzY3VsYXIgZW5k b3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciBpbiB0aGUgaHVtYW4gY29ycHVzIGx1dGV1bTwvdGl0bGU+ PHNlY29uZGFyeS10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwvc2Vjb25kYXJ5LXRpdGxl PjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkogQ2xpbiBFbmRvY3Jpbm9sIE1ldGFi PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDI3LTM0PC9wYWdlcz48dm9sdW1lPjkw PC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGVkaXRpb24+MjAwNC8xMC8xNjwvZWRpdGlvbj48 a2V5d29yZHM+PGtleXdvcmQ+QWR1bHQ8L2tleXdvcmQ+PGtleXdvcmQ+Q29ycHVzIEx1dGV1bS8q bWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVt YW5zPC9rZXl3b3JkPjxrZXl3b3JkPkltbXVub2hpc3RvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3 b3JkPkluIFNpdHUgSHlicmlkaXphdGlvbjwva2V5d29yZD48a2V5d29yZD5MdXRlYWwgUGhhc2U8 L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+UHJvZ2VzdGVy b25lL2Jsb29kPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSwgTWVzc2VuZ2VyL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJhbnNjcmlwdGFzZSBQb2x5bWVyYXNlIENoYWluIFJlYWN0 aW9uPC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3Ig QS9hbmFseXNpcy8qZ2VuZXRpY3MvcGh5c2lvbG9neTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRl cz48eWVhcj4yMDA1PC95ZWFyPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9kYXRlPjwvcHViLWRhdGVz PjwvZGF0ZXM+PGlzYm4+MDAyMS05NzJYIChQcmludCkmI3hEOzAwMjEtOTcyWCAoTGlua2luZyk8 L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTU0ODMwOTM8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0 ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNn aT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91 aWRzPTE1NDgzMDkzPC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291 cmNlLW51bT5qYy4yMDA0LTA4NDMgW3BpaV0mI3hEOzEwLjEyMTAvamMuMjAwNC0wODQzPC9lbGVj dHJvbmljLXJlc291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0Np dGU+PC9FbmROb3RlPgB= ADDIN EN.CITE.DATA (Fraser, et al., 2005)
	Alteration of prokineticin-1 can induces several biochimical abnormalities characterizing eutopic endometrium in endometriosis	ADDIN EN.CITE <EndNote"/><Cite"/><Author"/>Tiberi</Author"/><RecNum"/>170</RecNum"/><record"/><rec-number"/>170</rec-number"/><foreign-keys"/><key app="EN" db-id="592p2xa97z5te8efp9bpfxt3xdertaxvdf2t""/>170</key"/></foreign-keys"/><ref-type name="Journal Article""/>17</ref-type"/><contributors"/><authors"/><author"/>Tiberi, F.</author"/><author"/>Tropea, A.</author"/><author"/>Apa, R.</author"/><author"/>Romani, F.</author"/><author"/>Lanzone, A.</author"/><author"/>Marana, R.</author"/></authors"/></contributors"/><auth-address"/>Istituto Scientifico Internazionale (ISI) Paolo VI, Universita Cattolica del Sacro Cuore (UCSC), 00168 Rome, Italy. [e-mail]</auth-address"/><titles"/><title"/>Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis</title"/><secondary-title"/>Fertil Steril</secondary-title"/></titles"/><periodical"/><full-title"/>Fertil Steril</full-title"/></periodical"/><pages"/>2145-9</pages"/><volume"/>93</volume"/><number"/>7</number"/><edition"/>2009/03/17</edition"/><keywords"/><keyword"/>Adult</keyword"/><keyword"/>Biopsy</keyword"/><keyword"/>Endometriosis/*genetics/metabolism/pathology</keyword"/><keyword"/>Endometrium/*metabolism/pathology</keyword"/><keyword"/>Female</keyword"/><keyword"/>Health</keyword"/><keyword"/>Humans</keyword"/><keyword"/>Luteal Phase/genetics/metabolism</keyword"/><keyword"/>RNA, Messenger/metabolism</keyword"/><keyword"/>Uterine Diseases/*genetics/metabolism/pathology</keyword"/><keyword"/>Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/*genetics/metabolism</keyword"/></keywords"/><dates"/><year"/>2009</year"/><pub-dates"/><date"/>May 1</date"/></pub-dates"/></dates"/><isbn"/>1556-5653 (Electronic)&#xD;0015-0282 (Linking)</isbn"/><accession-num"/>19285664</accession-num"/><urls"/><related-urls"/><url"/>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19285664</url"/></related-urls"/></urls"/><electronic-resource-num"/>S0015-0282(09)00145-9 [pii]&#xD;10.1016/j.fertnstert.2009.01.105</electronic-resource-num"/><language"/>eng</language"/></record"/></Cite"/></EndNote"/>(Tiberi, et al., 2009)
Placentation and pregnancy	Prokineticin-1 and PKR1 expression is elevated in human decidua during early pregnancy. Prokineticin-1 via PKR1 regulates expression of host implatation-related gene.	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5FdmFuczwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+PFJl Y051bT4xNzE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3MTwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTcxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5F dmFucywgSi48L2F1dGhvcj48YXV0aG9yPkNhdGFsYW5vLCBSLiBELjwvYXV0aG9yPjxhdXRob3I+ TW9yZ2FuLCBLLjwvYXV0aG9yPjxhdXRob3I+Q3JpdGNobGV5LCBILiBPLjwvYXV0aG9yPjxhdXRo b3I+TWlsbGFyLCBSLiBQLjwvYXV0aG9yPjxhdXRob3I+SmFiYm91ciwgSC4gTi48L2F1dGhvcj48 L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5NZWRpY2FsIFJlc2VhcmNoIENv dW5jaWwgSHVtYW4gUmVwcm9kdWN0aXZlIFNjaWVuY2VzIFVuaXQsIFRoZSBRdWVlbiZhcG9zO3Mg TWVkaWNhbCBSZXNlYXJjaCBJbnN0aXR1dGUsIEVkaW5idXJnaCBFSDE2IDRUSiwgVW5pdGVkIEtp bmdkb20uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJva2luZXRpY2luIDEgc2lnbmFs aW5nIGFuZCBnZW5lIHJlZ3VsYXRpb24gaW4gZWFybHkgaHVtYW4gcHJlZ25hbmN5PC90aXRsZT48 c2Vjb25kYXJ5LXRpdGxlPkVuZG9jcmlub2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48 cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FbmRvY3Jpbm9sb2d5PC9mdWxsLXRpdGxlPjwvcGVyaW9k aWNhbD48cGFnZXM+Mjg3Ny04NzwvcGFnZXM+PHZvbHVtZT4xNDk8L3ZvbHVtZT48bnVtYmVyPjY8 L251bWJlcj48ZWRpdGlvbj4yMDA4LzAzLzE1PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5D ZWxscywgQ3VsdHVyZWQ8L2tleXdvcmQ+PGtleXdvcmQ+RE5BIFByaW1lcnM8L2tleXdvcmQ+PGtl eXdvcmQ+RGVjaWR1YS9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkVtYnJ5byBJbXBsYW50 YXRpb24vcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5FbmRvbWV0cml1bS9jeXRvbG9neS9w aHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0 cm9pbnRlc3RpbmFsIEhvcm1vbmVzL2dlbmV0aWNzLypwaHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3 b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NZW5zdHJ1YWwgQ3ljbGUvZ2VuZXRpY3MvcGh5 c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3kvZ2VuZXRpY3MvKnBoeXNpb2xvZ3k8 L2tleXdvcmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBHLVByb3RlaW4tQ291cGxlZC9nZW5ldGljcy8q cGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5SZXZlcnNlIFRyYW5zY3JpcHRhc2UgUG9seW1l cmFzZSBDaGFpbiBSZWFjdGlvbjwva2V5d29yZD48a2V5d29yZD5TaWduYWwgVHJhbnNkdWN0aW9u PC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3IsIEVu ZG9jcmluZS1HbGFuZC1EZXJpdmVkL2dlbmV0aWNzLypwaHlzaW9sb2d5PC9rZXl3b3JkPjwva2V5 d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+ PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDEzLTcyMjcgKFByaW50KSYjeEQ7MDAxMy03MjI3 IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xODMzOTcxMjwvYWNjZXNzaW9uLW51bT48 dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2VudHJl ei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9u JmFtcDtsaXN0X3VpZHM9MTgzMzk3MTI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0 cm9uaWMtcmVzb3VyY2UtbnVtPmVuLjIwMDctMTYzMyBbcGlpXSYjeEQ7MTAuMTIxMC9lbi4yMDA3 LTE2MzM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwv cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5FdmFuczwvQXV0aG9yPjxZZWFyPjIwMDg8L1llYXI+PFJl Y051bT4xNzE8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3MTwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTcxPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5F dmFucywgSi48L2F1dGhvcj48YXV0aG9yPkNhdGFsYW5vLCBSLiBELjwvYXV0aG9yPjxhdXRob3I+ TW9yZ2FuLCBLLjwvYXV0aG9yPjxhdXRob3I+Q3JpdGNobGV5LCBILiBPLjwvYXV0aG9yPjxhdXRo b3I+TWlsbGFyLCBSLiBQLjwvYXV0aG9yPjxhdXRob3I+SmFiYm91ciwgSC4gTi48L2F1dGhvcj48 L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5NZWRpY2FsIFJlc2VhcmNoIENv dW5jaWwgSHVtYW4gUmVwcm9kdWN0aXZlIFNjaWVuY2VzIFVuaXQsIFRoZSBRdWVlbiZhcG9zO3Mg TWVkaWNhbCBSZXNlYXJjaCBJbnN0aXR1dGUsIEVkaW5idXJnaCBFSDE2IDRUSiwgVW5pdGVkIEtp bmdkb20uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UHJva2luZXRpY2luIDEgc2lnbmFs aW5nIGFuZCBnZW5lIHJlZ3VsYXRpb24gaW4gZWFybHkgaHVtYW4gcHJlZ25hbmN5PC90aXRsZT48 c2Vjb25kYXJ5LXRpdGxlPkVuZG9jcmlub2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48 cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FbmRvY3Jpbm9sb2d5PC9mdWxsLXRpdGxlPjwvcGVyaW9k aWNhbD48cGFnZXM+Mjg3Ny04NzwvcGFnZXM+PHZvbHVtZT4xNDk8L3ZvbHVtZT48bnVtYmVyPjY8 L251bWJlcj48ZWRpdGlvbj4yMDA4LzAzLzE1PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5D ZWxscywgQ3VsdHVyZWQ8L2tleXdvcmQ+PGtleXdvcmQ+RE5BIFByaW1lcnM8L2tleXdvcmQ+PGtl eXdvcmQ+RGVjaWR1YS9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkVtYnJ5byBJbXBsYW50 YXRpb24vcGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5FbmRvbWV0cml1bS9jeXRvbG9neS9w aHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0 cm9pbnRlc3RpbmFsIEhvcm1vbmVzL2dlbmV0aWNzLypwaHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3 b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5NZW5zdHJ1YWwgQ3ljbGUvZ2VuZXRpY3MvcGh5 c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3kvZ2VuZXRpY3MvKnBoeXNpb2xvZ3k8 L2tleXdvcmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBHLVByb3RlaW4tQ291cGxlZC9nZW5ldGljcy8q cGh5c2lvbG9neTwva2V5d29yZD48a2V5d29yZD5SZXZlcnNlIFRyYW5zY3JpcHRhc2UgUG9seW1l cmFzZSBDaGFpbiBSZWFjdGlvbjwva2V5d29yZD48a2V5d29yZD5TaWduYWwgVHJhbnNkdWN0aW9u PC9rZXl3b3JkPjxrZXl3b3JkPlZhc2N1bGFyIEVuZG90aGVsaWFsIEdyb3d0aCBGYWN0b3IsIEVu ZG9jcmluZS1HbGFuZC1EZXJpdmVkL2dlbmV0aWNzLypwaHlzaW9sb2d5PC9rZXl3b3JkPjwva2V5 d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDg8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5KdW48L2RhdGU+ PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4wMDEzLTcyMjcgKFByaW50KSYjeEQ7MDAxMy03MjI3 IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4xODMzOTcxMjwvYWNjZXNzaW9uLW51bT48 dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWguZ292L2VudHJl ei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9u JmFtcDtsaXN0X3VpZHM9MTgzMzk3MTI8L3VybD48L3JlbGF0ZWQtdXJscz48L3VybHM+PGVsZWN0 cm9uaWMtcmVzb3VyY2UtbnVtPmVuLjIwMDctMTYzMyBbcGlpXSYjeEQ7MTAuMTIxMC9lbi4yMDA3 LTE2MzM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwv cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE.DATA (Evans, et al., 2008)
	Dysregulation of Prokineticin signaling in fallopian tube could affect fallopian tube smooth muscle cells contractility and embryo-tubal transport providing a potential cause for ectopic pregnancy	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGF3PC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48UmVj TnVtPjY3PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj42NzwvcmVjLW51bWJlcj48Zm9yZWln bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hkZXJ0 YXh2ZGYydCI+Njc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNoYXcs IEouIEwuPC9hdXRob3I+PGF1dGhvcj5EZW5pc29uLCBGLiBDLjwvYXV0aG9yPjxhdXRob3I+RXZh bnMsIEouPC9hdXRob3I+PGF1dGhvcj5EdXJubywgSy48L2F1dGhvcj48YXV0aG9yPldpbGxpYW1z LCBBLiBSLjwvYXV0aG9yPjxhdXRob3I+RW50cmljYW4sIEcuPC9hdXRob3I+PGF1dGhvcj5Dcml0 Y2hsZXksIEguIE8uPC9hdXRob3I+PGF1dGhvcj5KYWJib3VyLCBILiBOLjwvYXV0aG9yPjxhdXRo b3I+SG9ybmUsIEEuIFcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk ZHJlc3M+Q2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgUXVlZW4mYXBvcztzIE1lZGlj YWwgUmVzZWFyY2ggSW5zdGl0dXRlLCBVbml2ZXJzaXR5IG9mIEVkaW5idXJnaCwgRWRpbmJ1cmdo LCBTY290bGFuZCwgVW5pdGVkIEtpbmdkb20uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+ RXZpZGVuY2Ugb2YgcHJva2luZXRpY2luIGR5c3JlZ3VsYXRpb24gaW4gZmFsbG9waWFuIHR1YmUg ZnJvbSB3b21lbiB3aXRoIGVjdG9waWMgcHJlZ25hbmN5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl PkZlcnRpbCBTdGVyaWw8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs bC10aXRsZT5GZXJ0aWwgU3RlcmlsPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTYw MS04IGUxPC9wYWdlcz48dm9sdW1lPjk0PC92b2x1bWU+PG51bWJlcj41PC9udW1iZXI+PGVkaXRp b24+MjAxMC8wMS8wNjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5 d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5DZWxscywgQ3VsdHVyZWQ8L2tl eXdvcmQ+PGtleXdvcmQ+Q29udHJhY2VwdGl2ZSBBZ2VudHMsIEZlbWFsZS9waGFybWFjb2xvZ3k8 L2tleXdvcmQ+PGtleXdvcmQ+RXBpdGhlbGl1bS9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PkZhbGxvcGlhbiBUdWJlcy9jeXRvbG9neS9kcnVnIGVmZmVjdHMvKm1ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgSG9y bW9uZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3 b3JkPk1lZHJveHlwcm9nZXN0ZXJvbmUgQWNldGF0ZS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlIENvbnRyYWN0aW9uL3Bo eXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlLCBTbW9vdGgvbWV0YWJvbGlzbTwva2V5 d29yZD48a2V5d29yZD5OZXVyb3BlcHRpZGVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PlByZWduYW5jeTwva2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3ksIEVjdG9waWMvKm1ldGFib2xp c208L2tleXdvcmQ+PGtleXdvcmQ+Uk5BLCBNZXNzZW5nZXIvbWV0YWJvbGlzbTwva2V5d29yZD48 a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVkL21ldGFib2xpc208L2tleXdvcmQ+ PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+ VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jvd3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2 ZWQvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PC9r ZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0 ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTYtNTY1MyAoRWxlY3Ryb25pYykmI3hEOzAw MTUtMDI4MiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjAwNDc3Mzc8L2FjY2Vzc2lv bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv di9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1D aXRhdGlvbiZhbXA7bGlzdF91aWRzPTIwMDQ3NzM3PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT5TMDAxNS0wMjgyKDA5KTAzOTgyLVggW3BpaV0mI3hE OzEwLjEwMTYvai5mZXJ0bnN0ZXJ0LjIwMDkuMTAuMDYxPC9lbGVjdHJvbmljLXJlc291cmNlLW51 bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaGF3PC9BdXRob3I+PFllYXI+MjAxMDwvWWVhcj48UmVj TnVtPjY3PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj42NzwvcmVjLW51bWJlcj48Zm9yZWln bi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hkZXJ0 YXh2ZGYydCI+Njc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBB cnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPlNoYXcs IEouIEwuPC9hdXRob3I+PGF1dGhvcj5EZW5pc29uLCBGLiBDLjwvYXV0aG9yPjxhdXRob3I+RXZh bnMsIEouPC9hdXRob3I+PGF1dGhvcj5EdXJubywgSy48L2F1dGhvcj48YXV0aG9yPldpbGxpYW1z LCBBLiBSLjwvYXV0aG9yPjxhdXRob3I+RW50cmljYW4sIEcuPC9hdXRob3I+PGF1dGhvcj5Dcml0 Y2hsZXksIEguIE8uPC9hdXRob3I+PGF1dGhvcj5KYWJib3VyLCBILiBOLjwvYXV0aG9yPjxhdXRo b3I+SG9ybmUsIEEuIFcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk ZHJlc3M+Q2VudHJlIGZvciBSZXByb2R1Y3RpdmUgQmlvbG9neSwgUXVlZW4mYXBvcztzIE1lZGlj YWwgUmVzZWFyY2ggSW5zdGl0dXRlLCBVbml2ZXJzaXR5IG9mIEVkaW5idXJnaCwgRWRpbmJ1cmdo LCBTY290bGFuZCwgVW5pdGVkIEtpbmdkb20uPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+ RXZpZGVuY2Ugb2YgcHJva2luZXRpY2luIGR5c3JlZ3VsYXRpb24gaW4gZmFsbG9waWFuIHR1YmUg ZnJvbSB3b21lbiB3aXRoIGVjdG9waWMgcHJlZ25hbmN5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl PkZlcnRpbCBTdGVyaWw8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVs bC10aXRsZT5GZXJ0aWwgU3RlcmlsPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MTYw MS04IGUxPC9wYWdlcz48dm9sdW1lPjk0PC92b2x1bWU+PG51bWJlcj41PC9udW1iZXI+PGVkaXRp b24+MjAxMC8wMS8wNjwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5 d29yZD48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29yZD5DZWxscywgQ3VsdHVyZWQ8L2tl eXdvcmQ+PGtleXdvcmQ+Q29udHJhY2VwdGl2ZSBBZ2VudHMsIEZlbWFsZS9waGFybWFjb2xvZ3k8 L2tleXdvcmQ+PGtleXdvcmQ+RXBpdGhlbGl1bS9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PkZhbGxvcGlhbiBUdWJlcy9jeXRvbG9neS9kcnVnIGVmZmVjdHMvKm1ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+RmVtYWxlPC9rZXl3b3JkPjxrZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgSG9y bW9uZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3 b3JkPk1lZHJveHlwcm9nZXN0ZXJvbmUgQWNldGF0ZS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+TWlkZGxlIEFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlIENvbnRyYWN0aW9uL3Bo eXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TXVzY2xlLCBTbW9vdGgvbWV0YWJvbGlzbTwva2V5 d29yZD48a2V5d29yZD5OZXVyb3BlcHRpZGVzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PlByZWduYW5jeTwva2V5d29yZD48a2V5d29yZD5QcmVnbmFuY3ksIEVjdG9waWMvKm1ldGFib2xp c208L2tleXdvcmQ+PGtleXdvcmQ+Uk5BLCBNZXNzZW5nZXIvbWV0YWJvbGlzbTwva2V5d29yZD48 a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVkL21ldGFib2xpc208L2tleXdvcmQ+ PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+ VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jvd3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2 ZWQvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+WW91bmcgQWR1bHQ8L2tleXdvcmQ+PC9r ZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAxMDwveWVhcj48cHViLWRhdGVzPjxkYXRlPk9jdDwvZGF0 ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjE1NTYtNTY1MyAoRWxlY3Ryb25pYykmI3hEOzAw MTUtMDI4MiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MjAwNDc3Mzc8L2FjY2Vzc2lv bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv di9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1D aXRhdGlvbiZhbXA7bGlzdF91aWRzPTIwMDQ3NzM3PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT5TMDAxNS0wMjgyKDA5KTAzOTgyLVggW3BpaV0mI3hE OzEwLjEwMTYvai5mZXJ0bnN0ZXJ0LjIwMDkuMTAuMDYxPC9lbGVjdHJvbmljLXJlc291cmNlLW51 bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPgB= ADDIN EN.CITE.DATA (Shaw, et al., 2010)
	Prokineticin-1 and its receptor gene polymorphism and haplotype were associated with idiopathic recurrent pregnancy loss. These three gene contribute to recurent pregnancy loss in the Taiwanese Han population	ADDIN EN.CITE <EndNote"/><Cite"/><Author"/>Su</Author"/><RecNum"/>172</RecNum"/><record"/><rec-number"/>172</rec-number"/><foreign-keys"/><key app="EN" db-id="592p2xa97z5te8efp9bpfxt3xdertaxvdf2t""/>172</key"/></foreign-keys"/><ref-type name="Journal Article""/>17</ref-type"/><contributors"/><authors"/><author"/>Su, M. T.</author"/><author"/>Lin, S. H.</author"/><author"/>Lee, I. W.</author"/><author"/>Chen, Y. C.</author"/><author"/>Hsu, C. C.</author"/><author"/>Pan, H. A.</author"/><author"/>Kuo, P. L.</author"/></authors"/></contributors"/><auth-address"/>Division of Genetics, Department of Obstetrics and Gynecology, National Cheng Kung University, Tainan, Taiwan.</auth-address"/><titles"/><title"/>Polymorphisms of endocrine gland-derived vascular endothelial growth factor gene and its receptor genes are associated with recurrent pregnancy loss</title"/><secondary-title"/>Hum Reprod</secondary-title"/></titles"/><periodical"/><full-title"/>Hum Reprod</full-title"/></periodical"/><pages"/>2923-30</pages"/><volume"/>25</volume"/><number"/>11</number"/><edition"/>2010/09/18</edition"/><keywords"/><keyword"/>Abortion, Habitual/*genetics</keyword"/><keyword"/>Case-Control Studies</keyword"/><keyword"/>Female</keyword"/><keyword"/>Humans</keyword"/><keyword"/>Polymorphism, Single Nucleotide</keyword"/><keyword"/>Pregnancy</keyword"/><keyword"/>Receptors, G-Protein-Coupled/*genetics</keyword"/><keyword"/>Receptors, Peptide/*genetics</keyword"/><keyword"/>Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/*genetics</keyword"/></keywords"/><dates"/><pub-dates"/><date"/>Nov</date"/></pub-dates"/></dates"/><isbn"/>1460-2350 (Electronic)&#xD;0268-1161 (Linking)</isbn"/><accession-num"/>20847187</accession-num"/><urls"/><related-urls"/><url"/>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=20847187</url"/></related-urls"/></urls"/><electronic-resource-num"/>deq256 [pii]&#xD;10.1093/humrep/deq256</electronic-resource-num"/><language"/>eng</language"/></record"/></Cite"/></EndNote"/>(Su, et al.)
Kallman syndrome	Insufficient prokineticin signaling leads to abnormal development of the olfactory system and reproductive axis in man	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Eb2RlPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVj TnVtPjExODwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTE4PC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xMTg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkRv ZGUsIEMuPC9hdXRob3I+PGF1dGhvcj5UZWl4ZWlyYSwgTC48L2F1dGhvcj48YXV0aG9yPkxldmls bGllcnMsIEouPC9hdXRob3I+PGF1dGhvcj5Gb3V2ZWF1dCwgQy48L2F1dGhvcj48YXV0aG9yPkJv dWNoYXJkLCBQLjwvYXV0aG9yPjxhdXRob3I+S290dGxlciwgTS4gTC48L2F1dGhvcj48YXV0aG9y Pkxlc3BpbmFzc2UsIEouPC9hdXRob3I+PGF1dGhvcj5MaWVuaGFyZHQtUm91c3NpZSwgQS48L2F1 dGhvcj48YXV0aG9yPk1hdGhpZXUsIE0uPC9hdXRob3I+PGF1dGhvcj5Nb2VybWFuLCBBLjwvYXV0 aG9yPjxhdXRob3I+TW9yZ2FuLCBHLjwvYXV0aG9yPjxhdXRob3I+TXVyYXQsIEEuPC9hdXRob3I+ PGF1dGhvcj5Ub3VibGFuYywgSi4gRS48L2F1dGhvcj48YXV0aG9yPldvbGN6eW5za2ksIFMuPC9h dXRob3I+PGF1dGhvcj5EZWxwZWNoLCBNLjwvYXV0aG9yPjxhdXRob3I+UGV0aXQsIEMuPC9hdXRo b3I+PGF1dGhvcj5Zb3VuZywgSi48L2F1dGhvcj48YXV0aG9yPkhhcmRlbGluLCBKLiBQLjwvYXV0 aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkluc3RpdHV0IENvY2hp biwgSU5TRVJNIFU1NjcsIFVuaXZlcnNpdGUgUmVuZSBEZXNjYXJ0ZXMsIFBhcmlzLCBGcmFuY2Uu IGRvZGVAY29jaGluLmluc2VybS5mcjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkthbGxt YW5uIHN5bmRyb21lOiBtdXRhdGlvbnMgaW4gdGhlIGdlbmVzIGVuY29kaW5nIHByb2tpbmV0aWNp bi0yIGFuZCBwcm9raW5ldGljaW4gcmVjZXB0b3ItMjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Q TG9TIEdlbmV0PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0 bGU+UExvUyBHZW5ldDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPmUxNzU8L3BhZ2Vz Pjx2b2x1bWU+Mjwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZWRpdGlvbj4yMDA2LzEwLzI0 PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DaHJvbW9zb21lIFNlZ3JlZ2F0aW9uL2dlbmV0 aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkNocm9tb3NvbWVzLCBIdW1hbi9nZW5ldGljczwva2V5d29y ZD48a2V5d29yZD5Db2hvcnQgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5FeG9ucy9nZW5ldGlj czwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+R2FzdHJvaW50ZXN0 aW5hbCBIb3Jtb25lcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk PjxrZXl3b3JkPkthbGxtYW5uIFN5bmRyb21lLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5N YWxlPC9rZXl3b3JkPjxrZXl3b3JkPk11dGF0aW9uLypnZW5ldGljczwva2V5d29yZD48a2V5d29y ZD5OZXVyb3BlcHRpZGVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5QZWRpZ3JlZTwva2V5 d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVkLypnZW5ldGljczwva2V5 d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIFBlcHRpZGUvKmdlbmV0aWNzPC9rZXl3b3JkPjwva2V5 d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3QgMjA8L2Rh dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTUzLTc0MDQgKEVsZWN0cm9uaWMpJiN4RDsx NTUzLTczOTAgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE3MDU0Mzk5PC9hY2Nlc3Np b24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5n b3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9 Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNzA1NDM5OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MDYtUExHRS1SQS0wMTA4UjMgW3BpaV0mI3hEOzEw LjEzNzEvam91cm5hbC5wZ2VuLjAwMjAxNzU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5n dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Eb2RlPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVj TnVtPjExODwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTE4PC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xMTg8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkRv ZGUsIEMuPC9hdXRob3I+PGF1dGhvcj5UZWl4ZWlyYSwgTC48L2F1dGhvcj48YXV0aG9yPkxldmls bGllcnMsIEouPC9hdXRob3I+PGF1dGhvcj5Gb3V2ZWF1dCwgQy48L2F1dGhvcj48YXV0aG9yPkJv dWNoYXJkLCBQLjwvYXV0aG9yPjxhdXRob3I+S290dGxlciwgTS4gTC48L2F1dGhvcj48YXV0aG9y Pkxlc3BpbmFzc2UsIEouPC9hdXRob3I+PGF1dGhvcj5MaWVuaGFyZHQtUm91c3NpZSwgQS48L2F1 dGhvcj48YXV0aG9yPk1hdGhpZXUsIE0uPC9hdXRob3I+PGF1dGhvcj5Nb2VybWFuLCBBLjwvYXV0 aG9yPjxhdXRob3I+TW9yZ2FuLCBHLjwvYXV0aG9yPjxhdXRob3I+TXVyYXQsIEEuPC9hdXRob3I+ PGF1dGhvcj5Ub3VibGFuYywgSi4gRS48L2F1dGhvcj48YXV0aG9yPldvbGN6eW5za2ksIFMuPC9h dXRob3I+PGF1dGhvcj5EZWxwZWNoLCBNLjwvYXV0aG9yPjxhdXRob3I+UGV0aXQsIEMuPC9hdXRo b3I+PGF1dGhvcj5Zb3VuZywgSi48L2F1dGhvcj48YXV0aG9yPkhhcmRlbGluLCBKLiBQLjwvYXV0 aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkluc3RpdHV0IENvY2hp biwgSU5TRVJNIFU1NjcsIFVuaXZlcnNpdGUgUmVuZSBEZXNjYXJ0ZXMsIFBhcmlzLCBGcmFuY2Uu IGRvZGVAY29jaGluLmluc2VybS5mcjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkthbGxt YW5uIHN5bmRyb21lOiBtdXRhdGlvbnMgaW4gdGhlIGdlbmVzIGVuY29kaW5nIHByb2tpbmV0aWNp bi0yIGFuZCBwcm9raW5ldGljaW4gcmVjZXB0b3ItMjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Q TG9TIEdlbmV0PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0 bGU+UExvUyBHZW5ldDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPmUxNzU8L3BhZ2Vz Pjx2b2x1bWU+Mjwvdm9sdW1lPjxudW1iZXI+MTA8L251bWJlcj48ZWRpdGlvbj4yMDA2LzEwLzI0 PC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DaHJvbW9zb21lIFNlZ3JlZ2F0aW9uL2dlbmV0 aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkNocm9tb3NvbWVzLCBIdW1hbi9nZW5ldGljczwva2V5d29y ZD48a2V5d29yZD5Db2hvcnQgU3R1ZGllczwva2V5d29yZD48a2V5d29yZD5FeG9ucy9nZW5ldGlj czwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+R2FzdHJvaW50ZXN0 aW5hbCBIb3Jtb25lcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3Jk PjxrZXl3b3JkPkthbGxtYW5uIFN5bmRyb21lLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5N YWxlPC9rZXl3b3JkPjxrZXl3b3JkPk11dGF0aW9uLypnZW5ldGljczwva2V5d29yZD48a2V5d29y ZD5OZXVyb3BlcHRpZGVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5QZWRpZ3JlZTwva2V5 d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVkLypnZW5ldGljczwva2V5 d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIFBlcHRpZGUvKmdlbmV0aWNzPC9rZXl3b3JkPjwva2V5 d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDY8L3llYXI+PHB1Yi1kYXRlcz48ZGF0ZT5PY3QgMjA8L2Rh dGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTUzLTc0MDQgKEVsZWN0cm9uaWMpJiN4RDsx NTUzLTczOTAgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE3MDU0Mzk5PC9hY2Nlc3Np b24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5n b3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9 Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNzA1NDM5OTwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJs cz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MDYtUExHRS1SQS0wMTA4UjMgW3BpaV0mI3hEOzEw LjEzNzEvam91cm5hbC5wZ2VuLjAwMjAxNzU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5n dWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE.DATA (Dode, et al., 2006)
	Mutation in prokineticin-2 and PKR2 genes underlie both Kallman sydrome and idiopathic hypogonadotropic hypogonadism	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xlPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVj TnVtPjE0OTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTQ5PC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xNDk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNv bGUsIEwuIFcuPC9hdXRob3I+PGF1dGhvcj5TaWRpcywgWS48L2F1dGhvcj48YXV0aG9yPlpoYW5n LCBDLjwvYXV0aG9yPjxhdXRob3I+UXVpbnRvbiwgUi48L2F1dGhvcj48YXV0aG9yPlBsdW1tZXIs IEwuPC9hdXRob3I+PGF1dGhvcj5QaWduYXRlbGxpLCBELjwvYXV0aG9yPjxhdXRob3I+SHVnaGVz LCBWLiBBLjwvYXV0aG9yPjxhdXRob3I+RHd5ZXIsIEEuIEEuPC9hdXRob3I+PGF1dGhvcj5SYWl2 aW8sIFQuPC9hdXRob3I+PGF1dGhvcj5IYXllcywgRi4gSi48L2F1dGhvcj48YXV0aG9yPlNlbWlu YXJhLCBTLiBCLjwvYXV0aG9yPjxhdXRob3I+SHVvdCwgQy48L2F1dGhvcj48YXV0aG9yPkFsb3Ms IE4uPC9hdXRob3I+PGF1dGhvcj5TcGVpc2VyLCBQLjwvYXV0aG9yPjxhdXRob3I+VGFrZXNoaXRh LCBBLjwvYXV0aG9yPjxhdXRob3I+VmFuIFZsaWV0LCBHLjwvYXV0aG9yPjxhdXRob3I+UGVhcmNl LCBTLjwvYXV0aG9yPjxhdXRob3I+Q3Jvd2xleSwgVy4gRi4sIEpyLjwvYXV0aG9yPjxhdXRob3I+ WmhvdSwgUS4gWS48L2F1dGhvcj48YXV0aG9yPlBpdHRlbG91ZCwgTi48L2F1dGhvcj48L2F1dGhv cnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5SZXByb2R1Y3RpdmUgRW5kb2NyaW5lIFVu aXQgb2YgdGhlIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIEhhcnZhcmQgUmVwcm9kdWN0aXZlIEVu ZG9jcmluZSBTY2llbmNlcyBDZW50ZXIsIE1hc3NhY2h1c2V0dHMgR2VuZXJhbCBIb3NwaXRhbCwg Qm9zdG9uLCBNYXNzYWNodXNldHRzIDAyMTE0LCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48 dGl0bGU+TXV0YXRpb25zIGluIHByb2tpbmV0aWNpbiAyIGFuZCBwcm9raW5ldGljaW4gcmVjZXB0 b3IgMiBnZW5lcyBpbiBodW1hbiBnb25hZG90cm9waGluLXJlbGVhc2luZyBob3Jtb25lIGRlZmlj aWVuY3k6IG1vbGVjdWxhciBnZW5ldGljcyBhbmQgY2xpbmljYWwgc3BlY3RydW08L3RpdGxlPjxz ZWNvbmRhcnktdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L3NlY29uZGFyeS10aXRsZT48 L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwv ZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjM1NTEtOTwvcGFnZXM+PHZvbHVtZT45Mzwv dm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxlZGl0aW9uPjIwMDgvMDYvMTk8L2VkaXRpb24+PGtl eXdvcmRzPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWVxdW9yaW4vZ2Vu ZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5d29yZD5DSE8gQ2Vs bHM8L2tleXdvcmQ+PGtleXdvcmQ+Q3JpY2V0aW5hZTwva2V5d29yZD48a2V5d29yZD5DcmljZXR1 bHVzPC9rZXl3b3JkPjxrZXl3b3JkPkROQSBNdXRhdGlvbmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr ZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVz LypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5HZW5lIEZyZXF1ZW5jeTwva2V5d29yZD48a2V5 d29yZD5HZW5ldGljIEhldGVyb2dlbmVpdHk8L2tleXdvcmQ+PGtleXdvcmQ+R2Vub3R5cGU8L2tl eXdvcmQ+PGtleXdvcmQ+R29uYWRvdHJvcGluLVJlbGVhc2luZyBIb3Jtb25lLypkZWZpY2llbmN5 PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBvZ29uYWRpc20v KmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkthbGxtYW5uIFN5bmRyb21lL2dlbmV0aWNzPC9r ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TW9kZWxzLCBCaW9sb2dpY2Fs PC9rZXl3b3JkPjxrZXl3b3JkPipNdXRhdGlvbiwgTWlzc2Vuc2U8L2tleXdvcmQ+PGtleXdvcmQ+ TmV1cm9wZXB0aWRlcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+UGVkaWdyZWU8L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBHLVByb3RlaW4tQ291cGxlZC8qZ2VuZXRpY3M8L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlLypnZW5ldGljczwva2V5d29yZD48a2V5d29y ZD5UcmFuc2ZlY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwveWVh cj48cHViLWRhdGVzPjxkYXRlPlNlcDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAw MjEtOTcyWCAoUHJpbnQpJiN4RDswMDIxLTk3MlggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t bnVtPjE4NTU5OTIyPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRw Oi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFt cDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xODU1OTkyMjwvdXJs PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+amMuMjAwNy0y NjU0IFtwaWldJiN4RDsxMC4xMjEwL2pjLjIwMDctMjY1NDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u dW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xlPC9BdXRob3I+PFllYXI+MjAwODwvWWVhcj48UmVj TnVtPjE0OTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTQ5PC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xNDk8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPkNv bGUsIEwuIFcuPC9hdXRob3I+PGF1dGhvcj5TaWRpcywgWS48L2F1dGhvcj48YXV0aG9yPlpoYW5n LCBDLjwvYXV0aG9yPjxhdXRob3I+UXVpbnRvbiwgUi48L2F1dGhvcj48YXV0aG9yPlBsdW1tZXIs IEwuPC9hdXRob3I+PGF1dGhvcj5QaWduYXRlbGxpLCBELjwvYXV0aG9yPjxhdXRob3I+SHVnaGVz LCBWLiBBLjwvYXV0aG9yPjxhdXRob3I+RHd5ZXIsIEEuIEEuPC9hdXRob3I+PGF1dGhvcj5SYWl2 aW8sIFQuPC9hdXRob3I+PGF1dGhvcj5IYXllcywgRi4gSi48L2F1dGhvcj48YXV0aG9yPlNlbWlu YXJhLCBTLiBCLjwvYXV0aG9yPjxhdXRob3I+SHVvdCwgQy48L2F1dGhvcj48YXV0aG9yPkFsb3Ms IE4uPC9hdXRob3I+PGF1dGhvcj5TcGVpc2VyLCBQLjwvYXV0aG9yPjxhdXRob3I+VGFrZXNoaXRh LCBBLjwvYXV0aG9yPjxhdXRob3I+VmFuIFZsaWV0LCBHLjwvYXV0aG9yPjxhdXRob3I+UGVhcmNl LCBTLjwvYXV0aG9yPjxhdXRob3I+Q3Jvd2xleSwgVy4gRi4sIEpyLjwvYXV0aG9yPjxhdXRob3I+ WmhvdSwgUS4gWS48L2F1dGhvcj48YXV0aG9yPlBpdHRlbG91ZCwgTi48L2F1dGhvcj48L2F1dGhv cnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5SZXByb2R1Y3RpdmUgRW5kb2NyaW5lIFVu aXQgb2YgdGhlIERlcGFydG1lbnQgb2YgTWVkaWNpbmUsIEhhcnZhcmQgUmVwcm9kdWN0aXZlIEVu ZG9jcmluZSBTY2llbmNlcyBDZW50ZXIsIE1hc3NhY2h1c2V0dHMgR2VuZXJhbCBIb3NwaXRhbCwg Qm9zdG9uLCBNYXNzYWNodXNldHRzIDAyMTE0LCBVU0EuPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48 dGl0bGU+TXV0YXRpb25zIGluIHByb2tpbmV0aWNpbiAyIGFuZCBwcm9raW5ldGljaW4gcmVjZXB0 b3IgMiBnZW5lcyBpbiBodW1hbiBnb25hZG90cm9waGluLXJlbGVhc2luZyBob3Jtb25lIGRlZmlj aWVuY3k6IG1vbGVjdWxhciBnZW5ldGljcyBhbmQgY2xpbmljYWwgc3BlY3RydW08L3RpdGxlPjxz ZWNvbmRhcnktdGl0bGU+SiBDbGluIEVuZG9jcmlub2wgTWV0YWI8L3NlY29uZGFyeS10aXRsZT48 L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5KIENsaW4gRW5kb2NyaW5vbCBNZXRhYjwv ZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjM1NTEtOTwvcGFnZXM+PHZvbHVtZT45Mzwv dm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxlZGl0aW9uPjIwMDgvMDYvMTk8L2VkaXRpb24+PGtl eXdvcmRzPjxrZXl3b3JkPkFkb2xlc2NlbnQ8L2tleXdvcmQ+PGtleXdvcmQ+QWVxdW9yaW4vZ2Vu ZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5d29yZD5DSE8gQ2Vs bHM8L2tleXdvcmQ+PGtleXdvcmQ+Q3JpY2V0aW5hZTwva2V5d29yZD48a2V5d29yZD5DcmljZXR1 bHVzPC9rZXl3b3JkPjxrZXl3b3JkPkROQSBNdXRhdGlvbmFsIEFuYWx5c2lzPC9rZXl3b3JkPjxr ZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVz LypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5HZW5lIEZyZXF1ZW5jeTwva2V5d29yZD48a2V5 d29yZD5HZW5ldGljIEhldGVyb2dlbmVpdHk8L2tleXdvcmQ+PGtleXdvcmQ+R2Vub3R5cGU8L2tl eXdvcmQ+PGtleXdvcmQ+R29uYWRvdHJvcGluLVJlbGVhc2luZyBIb3Jtb25lLypkZWZpY2llbmN5 PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5IeXBvZ29uYWRpc20v KmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkthbGxtYW5uIFN5bmRyb21lL2dlbmV0aWNzPC9r ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TW9kZWxzLCBCaW9sb2dpY2Fs PC9rZXl3b3JkPjxrZXl3b3JkPipNdXRhdGlvbiwgTWlzc2Vuc2U8L2tleXdvcmQ+PGtleXdvcmQ+ TmV1cm9wZXB0aWRlcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+UGVkaWdyZWU8L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBHLVByb3RlaW4tQ291cGxlZC8qZ2VuZXRpY3M8L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlLypnZW5ldGljczwva2V5d29yZD48a2V5d29y ZD5UcmFuc2ZlY3Rpb248L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwODwveWVh cj48cHViLWRhdGVzPjxkYXRlPlNlcDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAw MjEtOTcyWCAoUHJpbnQpJiN4RDswMDIxLTk3MlggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24t bnVtPjE4NTU5OTIyPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRw Oi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFt cDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xODU1OTkyMjwvdXJs PjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+amMuMjAwNy0y NjU0IFtwaWldJiN4RDsxMC4xMjEwL2pjLjIwMDctMjY1NDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u dW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE.DATA (Cole, et al., 2008)
Behaviour	Prokineticin-2 may play a role in the pathophysiology of mood disorders in the Japanese population	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LaXNoaTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT43NjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NzY8L3JlYy1udW1iZXI+PGZvcmVp Z24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1OTJwMnhhOTd6NXRlOGVmcDlicGZ4dDN4ZGVy dGF4dmRmMnQiPjc2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5LaXNo aSwgVC48L2F1dGhvcj48YXV0aG9yPktpdGFqaW1hLCBULjwvYXV0aG9yPjxhdXRob3I+VHN1bm9r YSwgVC48L2F1dGhvcj48YXV0aG9yPk9rdW11cmEsIFQuPC9hdXRob3I+PGF1dGhvcj5Ja2VkYSwg TS48L2F1dGhvcj48YXV0aG9yPk9rb2NoaSwgVC48L2F1dGhvcj48YXV0aG9yPktpbm9zaGl0YSwg WS48L2F1dGhvcj48YXV0aG9yPkthd2FzaGltYSwgSy48L2F1dGhvcj48YXV0aG9yPllhbWFub3Vj aGksIFkuPC9hdXRob3I+PGF1dGhvcj5PemFraSwgTi48L2F1dGhvcj48YXV0aG9yPkl3YXRhLCBO LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1l bnQgb2YgUHN5Y2hpYXRyeSwgRnVqaXRhIEhlYWx0aCBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRp Y2luZSwgVG95b2FrZSwgQWljaGksIDQ3MC0xMTkyLCBKYXBhbi4gdGFyb2tAZnVqaXRhLWh1LmFj LmpwPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UG9zc2libGUgYXNzb2NpYXRpb24gb2Yg cHJva2luZXRpY2luIDIgcmVjZXB0b3IgZ2VuZSAoUFJPS1IyKSB3aXRoIG1vb2QgZGlzb3JkZXJz IGluIHRoZSBKYXBhbmVzZSBwb3B1bGF0aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk5ldXJv bW9sZWN1bGFyIE1lZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs LXRpdGxlPk5ldXJvbW9sZWN1bGFyIE1lZDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz PjExNC0yMjwvcGFnZXM+PHZvbHVtZT4xMTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0 aW9uPjIwMDkvMDYvMjM8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk PjxrZXl3b3JkPkFuaW1hbHM8L2tleXdvcmQ+PGtleXdvcmQ+QXNpYW4gQ29udGluZW50YWwgQW5j ZXN0cnkgR3JvdXAvKmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkV4b25zPC9rZXl3b3JkPjxr ZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVz L2dlbmV0aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+R2VuZXRpYyBQcmVkaXNwb3Np dGlvbiB0byBEaXNlYXNlPC9rZXl3b3JkPjxrZXl3b3JkPkdlbm90eXBlPC9rZXl3b3JkPjxrZXl3 b3JkPkhhcGxvdHlwZXM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3Jk Pk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWljZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl ZDwva2V5d29yZD48a2V5d29yZD5Nb29kIERpc29yZGVycy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtl eXdvcmQ+TmV1cm9wZXB0aWRlcy9nZW5ldGljcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PipQb2x5bW9ycGhpc20sIFNpbmdsZSBOdWNsZW90aWRlPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2Vw dG9ycywgRy1Qcm90ZWluLUNvdXBsZWQvKmdlbmV0aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtl eXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlLypnZW5ldGljcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxr ZXl3b3JkPllvdW5nIEFkdWx0PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDk8 L3llYXI+PC9kYXRlcz48aXNibj4xNTU5LTExNzQgKEVsZWN0cm9uaWMpJiN4RDsxNTM1LTEwODQg KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE5NTQ0MDEzPC9hY2Nlc3Npb24tbnVtPjx1 cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6 L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24m YW1wO2xpc3RfdWlkcz0xOTU0NDAxMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry b25pYy1yZXNvdXJjZS1udW0+MTAuMTAwNy9zMTIwMTctMDA5LTgwNjctMDwvZWxlY3Ryb25pYy1y ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k Tm90ZT4A ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5LaXNoaTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT43NjwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+NzY8L3JlYy1udW1iZXI+PGZvcmVp Z24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI1OTJwMnhhOTd6NXRlOGVmcDlicGZ4dDN4ZGVy dGF4dmRmMnQiPjc2PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwg QXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5LaXNo aSwgVC48L2F1dGhvcj48YXV0aG9yPktpdGFqaW1hLCBULjwvYXV0aG9yPjxhdXRob3I+VHN1bm9r YSwgVC48L2F1dGhvcj48YXV0aG9yPk9rdW11cmEsIFQuPC9hdXRob3I+PGF1dGhvcj5Ja2VkYSwg TS48L2F1dGhvcj48YXV0aG9yPk9rb2NoaSwgVC48L2F1dGhvcj48YXV0aG9yPktpbm9zaGl0YSwg WS48L2F1dGhvcj48YXV0aG9yPkthd2FzaGltYSwgSy48L2F1dGhvcj48YXV0aG9yPllhbWFub3Vj aGksIFkuPC9hdXRob3I+PGF1dGhvcj5PemFraSwgTi48L2F1dGhvcj48YXV0aG9yPkl3YXRhLCBO LjwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1l bnQgb2YgUHN5Y2hpYXRyeSwgRnVqaXRhIEhlYWx0aCBVbml2ZXJzaXR5IFNjaG9vbCBvZiBNZWRp Y2luZSwgVG95b2FrZSwgQWljaGksIDQ3MC0xMTkyLCBKYXBhbi4gdGFyb2tAZnVqaXRhLWh1LmFj LmpwPC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+UG9zc2libGUgYXNzb2NpYXRpb24gb2Yg cHJva2luZXRpY2luIDIgcmVjZXB0b3IgZ2VuZSAoUFJPS1IyKSB3aXRoIG1vb2QgZGlzb3JkZXJz IGluIHRoZSBKYXBhbmVzZSBwb3B1bGF0aW9uPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPk5ldXJv bW9sZWN1bGFyIE1lZDwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs LXRpdGxlPk5ldXJvbW9sZWN1bGFyIE1lZDwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz PjExNC0yMjwvcGFnZXM+PHZvbHVtZT4xMTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxlZGl0 aW9uPjIwMDkvMDYvMjM8L2VkaXRpb24+PGtleXdvcmRzPjxrZXl3b3JkPkFkdWx0PC9rZXl3b3Jk PjxrZXl3b3JkPkFuaW1hbHM8L2tleXdvcmQ+PGtleXdvcmQ+QXNpYW4gQ29udGluZW50YWwgQW5j ZXN0cnkgR3JvdXAvKmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3b3JkPkV4b25zPC9rZXl3b3JkPjxr ZXl3b3JkPkZlbWFsZTwva2V5d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVz L2dlbmV0aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+R2VuZXRpYyBQcmVkaXNwb3Np dGlvbiB0byBEaXNlYXNlPC9rZXl3b3JkPjxrZXl3b3JkPkdlbm90eXBlPC9rZXl3b3JkPjxrZXl3 b3JkPkhhcGxvdHlwZXM8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3Jk Pk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWljZTwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdl ZDwva2V5d29yZD48a2V5d29yZD5Nb29kIERpc29yZGVycy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtl eXdvcmQ+TmV1cm9wZXB0aWRlcy9nZW5ldGljcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3Jk PipQb2x5bW9ycGhpc20sIFNpbmdsZSBOdWNsZW90aWRlPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2Vw dG9ycywgRy1Qcm90ZWluLUNvdXBsZWQvKmdlbmV0aWNzL21ldGFib2xpc208L2tleXdvcmQ+PGtl eXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlLypnZW5ldGljcy9tZXRhYm9saXNtPC9rZXl3b3JkPjxr ZXl3b3JkPllvdW5nIEFkdWx0PC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDk8 L3llYXI+PC9kYXRlcz48aXNibj4xNTU5LTExNzQgKEVsZWN0cm9uaWMpJiN4RDsxNTM1LTEwODQg KExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE5NTQ0MDEzPC9hY2Nlc3Npb24tbnVtPjx1 cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6 L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24m YW1wO2xpc3RfdWlkcz0xOTU0NDAxMzwvdXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ry b25pYy1yZXNvdXJjZS1udW0+MTAuMTAwNy9zMTIwMTctMDA5LTgwNjctMDwvZWxlY3Ryb25pYy1y ZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5k Tm90ZT4A ADDIN EN.CITE.DATA (Kishi, et al., 2009)
	Prokineticin-2 may play a role in the pathophysiology of methamphetamine dependance in the Japanese population	ADDIN EN.CITE <EndNote"/><Cite"/><Author"/>Kishi</Author"/><Year"/>2010</Year"/><RecNum"/>52</RecNum"/><record"/><rec-number"/>52</rec-number"/><foreign-keys"/><key app="EN" db-id="592p2xa97z5te8efp9bpfxt3xdertaxvdf2t""/>52</key"/></foreign-keys"/><ref-type name="Generic""/>13</ref-type"/><contributors"/><authors"/><author"/>Kishi, T.</author"/><author"/>Kitajima, T.</author"/><author"/>Tsunoka, T.</author"/><author"/>Okumura, T.</author"/><author"/>Kawashima, K.</author"/><author"/>Okochi, T.</author"/><author"/>Yamanouchi, Y.</author"/><author"/>Kinoshita, Y.</author"/><author"/>Ujike, H.</author"/><author"/>Inada, T.</author"/><author"/>Yamada, M.</author"/><author"/>Uchimura, N.</author"/><author"/>Sora, I.</author"/><author"/>Iyo, M.</author"/><author"/>Ozaki, N.</author"/><author"/>Iwata, N.</author"/></authors"/></contributors"/><auth-address"/>Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.</auth-address"/><titles"/><title"/>Lack of association between prokineticin 2 gene and Japanese methamphetamine dependence</title"/><secondary-title"/>Curr Neuropharmacol</secondary-title"/></titles"/><periodical"/><full-title"/>Curr Neuropharmacol</full-title"/></periodical"/><pages"/>133-6</pages"/><volume"/>9</volume"/><number"/>1</number"/><edition"/>2011/09/03</edition"/><dates"/><year"/>2010</year"/><pub-dates"/><date"/>Mar</date"/></pub-dates"/></dates"/><isbn"/>1875-6190 (Electronic)&#xD;1570-159X (Linking)</isbn"/><accession-num"/>21886578</accession-num"/><urls"/><related-urls"/><url"/>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=21886578</url"/></related-urls"/></urls"/><electronic-resource-num"/>10.2174/157015911795016994&#xD;CN-9-133 [pii]</electronic-resource-num"/><language"/>eng</language"/></record"/></Cite"/></EndNote"/>(Kishi, et al., 2010)
Cancer	Prokineticins and their receptors are expressed in human prostate and their levels increased with prostate malignancy	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXNxdWFsaTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+ PFJlY051bT4xMzQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEzNDwvcmVjLW51bWJlcj48 Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0 M3hkZXJ0YXh2ZGYydCI+MTM0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv cj5QYXNxdWFsaSwgRC48L2F1dGhvcj48YXV0aG9yPlJvc3NpLCBWLjwvYXV0aG9yPjxhdXRob3I+ U3RhaWJhbm8sIFMuPC9hdXRob3I+PGF1dGhvcj5EZSBSb3NhLCBHLjwvYXV0aG9yPjxhdXRob3I+ Q2hpZWZmaSwgUC48L2F1dGhvcj48YXV0aG9yPlByZXppb3NvLCBELjwvYXV0aG9yPjxhdXRob3I+ TWlyb25lLCBWLjwvYXV0aG9yPjxhdXRob3I+TWFzY29sbywgTS48L2F1dGhvcj48YXV0aG9yPlRy YW1vbnRhbm8sIEQuPC9hdXRob3I+PGF1dGhvcj5CZWxsYXN0ZWxsYSwgQS48L2F1dGhvcj48YXV0 aG9yPlNpbmlzaSwgQS4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt YWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIGFuZCBFeHBlcmltZW50YWwgTWVkaWNpbmUg YW5kIFN1cmdlcnksIEVuZG9jcmluZSBVbml0LCBTZWNvbmQgVW5pdmVyc2l0eSBvZiBOYXBvbGks IFZpYSBQYW5zaW5pIDUsIDgwMTMxIE5hcG9saSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxl cz48dGl0bGU+VGhlIGVuZG9jcmluZS1nbGFuZC1kZXJpdmVkIHZhc2N1bGFyIGVuZG90aGVsaWFs IGdyb3d0aCBmYWN0b3IgKEVHLVZFR0YpL3Byb2tpbmV0aWNpbiAxIGFuZCAyIGFuZCByZWNlcHRv ciBleHByZXNzaW9uIGluIGh1bWFuIHByb3N0YXRlOiBVcC1yZWd1bGF0aW9uIG9mIEVHLVZFR0Yv cHJva2luZXRpY2luIDEgd2l0aCBtYWxpZ25hbmN5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVu ZG9jcmlub2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10 aXRsZT5FbmRvY3Jpbm9sb2d5PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDI0NS01 MTwvcGFnZXM+PHZvbHVtZT4xNDc8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJlcj48ZWRpdGlvbj4y MDA2LzA2LzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5CbG90dGluZywgV2VzdGVybjwv a2V5d29yZD48a2V5d29yZD5DZWxsIExpbmU8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBMaW5lLCBU dW1vcjwva2V5d29yZD48a2V5d29yZD5FcGl0aGVsaWFsIENlbGxzL2NoZW1pc3RyeTwva2V5d29y ZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzL2FuYWx5c2lzLypnZW5ldGljczwv a2V5d29yZD48a2V5d29yZD5HZW5lIEV4cHJlc3Npb24gUmVndWxhdGlvbiwgTmVvcGxhc3RpYy8q Z2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkltbXVu b2hpc3RvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+ TmV1cm9wZXB0aWRlcy9hbmFseXNpcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3Rh dGUvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3b3JkPlByb3N0YXRpYyBIeXBlcnBsYXNpYS9tZXRh Ym9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlByb3N0YXRpYyBOZW9wbGFzbXMvY2hlbWlzdHJ5Lypt ZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSwgTWVzc2VuZ2VyL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgRy1Qcm90ZWluLUNvdXBsZWQvKmdlbmV0aWNzPC9rZXl3 b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgUGVwdGlkZS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdv cmQ+UmV2ZXJzZSBUcmFuc2NyaXB0YXNlIFBvbHltZXJhc2UgQ2hhaW4gUmVhY3Rpb248L2tleXdv cmQ+PGtleXdvcmQ+VXAtUmVndWxhdGlvbjwva2V5d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRv dGhlbGlhbCBHcm93dGggRmFjdG9yLCBFbmRvY3JpbmUtR2xhbmQtRGVyaXZlZC9hbmFseXNpcy8q Z2VuZXRpY3M8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHVi LWRhdGVzPjxkYXRlPlNlcDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMTMtNzIy NyAoUHJpbnQpJiN4RDswMDEzLTcyMjcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2 NzYzMDY1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3 Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1Q dWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNjc2MzA2NTwvdXJsPjwvcmVs YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+ZW4uMjAwNi0wNjE0IFtw aWldJiN4RDsxMC4xMjEwL2VuLjIwMDYtMDYxNDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxh bmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXNxdWFsaTwvQXV0aG9yPjxZZWFyPjIwMDY8L1llYXI+ PFJlY051bT4xMzQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEzNDwvcmVjLW51bWJlcj48 Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0 M3hkZXJ0YXh2ZGYydCI+MTM0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv cj5QYXNxdWFsaSwgRC48L2F1dGhvcj48YXV0aG9yPlJvc3NpLCBWLjwvYXV0aG9yPjxhdXRob3I+ U3RhaWJhbm8sIFMuPC9hdXRob3I+PGF1dGhvcj5EZSBSb3NhLCBHLjwvYXV0aG9yPjxhdXRob3I+ Q2hpZWZmaSwgUC48L2F1dGhvcj48YXV0aG9yPlByZXppb3NvLCBELjwvYXV0aG9yPjxhdXRob3I+ TWlyb25lLCBWLjwvYXV0aG9yPjxhdXRob3I+TWFzY29sbywgTS48L2F1dGhvcj48YXV0aG9yPlRy YW1vbnRhbm8sIEQuPC9hdXRob3I+PGF1dGhvcj5CZWxsYXN0ZWxsYSwgQS48L2F1dGhvcj48YXV0 aG9yPlNpbmlzaSwgQS4gQS48L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgt YWRkcmVzcz5EZXBhcnRtZW50IG9mIENsaW5pY2FsIGFuZCBFeHBlcmltZW50YWwgTWVkaWNpbmUg YW5kIFN1cmdlcnksIEVuZG9jcmluZSBVbml0LCBTZWNvbmQgVW5pdmVyc2l0eSBvZiBOYXBvbGks IFZpYSBQYW5zaW5pIDUsIDgwMTMxIE5hcG9saSwgSXRhbHkuPC9hdXRoLWFkZHJlc3M+PHRpdGxl cz48dGl0bGU+VGhlIGVuZG9jcmluZS1nbGFuZC1kZXJpdmVkIHZhc2N1bGFyIGVuZG90aGVsaWFs IGdyb3d0aCBmYWN0b3IgKEVHLVZFR0YpL3Byb2tpbmV0aWNpbiAxIGFuZCAyIGFuZCByZWNlcHRv ciBleHByZXNzaW9uIGluIGh1bWFuIHByb3N0YXRlOiBVcC1yZWd1bGF0aW9uIG9mIEVHLVZFR0Yv cHJva2luZXRpY2luIDEgd2l0aCBtYWxpZ25hbmN5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVu ZG9jcmlub2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10 aXRsZT5FbmRvY3Jpbm9sb2d5PC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+NDI0NS01 MTwvcGFnZXM+PHZvbHVtZT4xNDc8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJlcj48ZWRpdGlvbj4y MDA2LzA2LzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5CbG90dGluZywgV2VzdGVybjwv a2V5d29yZD48a2V5d29yZD5DZWxsIExpbmU8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBMaW5lLCBU dW1vcjwva2V5d29yZD48a2V5d29yZD5FcGl0aGVsaWFsIENlbGxzL2NoZW1pc3RyeTwva2V5d29y ZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzL2FuYWx5c2lzLypnZW5ldGljczwv a2V5d29yZD48a2V5d29yZD5HZW5lIEV4cHJlc3Npb24gUmVndWxhdGlvbiwgTmVvcGxhc3RpYy8q Z2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkltbXVu b2hpc3RvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+ TmV1cm9wZXB0aWRlcy9hbmFseXNpcy8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+UHJvc3Rh dGUvY2hlbWlzdHJ5PC9rZXl3b3JkPjxrZXl3b3JkPlByb3N0YXRpYyBIeXBlcnBsYXNpYS9tZXRh Ym9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlByb3N0YXRpYyBOZW9wbGFzbXMvY2hlbWlzdHJ5Lypt ZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSwgTWVzc2VuZ2VyL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgRy1Qcm90ZWluLUNvdXBsZWQvKmdlbmV0aWNzPC9rZXl3 b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgUGVwdGlkZS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdv cmQ+UmV2ZXJzZSBUcmFuc2NyaXB0YXNlIFBvbHltZXJhc2UgQ2hhaW4gUmVhY3Rpb248L2tleXdv cmQ+PGtleXdvcmQ+VXAtUmVndWxhdGlvbjwva2V5d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRv dGhlbGlhbCBHcm93dGggRmFjdG9yLCBFbmRvY3JpbmUtR2xhbmQtRGVyaXZlZC9hbmFseXNpcy8q Z2VuZXRpY3M8L2tleXdvcmQ+PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNjwveWVhcj48cHVi LWRhdGVzPjxkYXRlPlNlcDwvZGF0ZT48L3B1Yi1kYXRlcz48L2RhdGVzPjxpc2JuPjAwMTMtNzIy NyAoUHJpbnQpJiN4RDswMDEzLTcyMjcgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE2 NzYzMDY1PC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3 Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1Q dWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNjc2MzA2NTwvdXJsPjwvcmVs YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+ZW4uMjAwNi0wNjE0IFtw aWldJiN4RDsxMC4xMjEwL2VuLjIwMDYtMDYxNDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxh bmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE.DATA (Pasquali, et al., 2006)
	Prokineticin-1 favors neuroblastoma progression	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZ2FuPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj TnVtPjExMDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTEwPC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xMTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5n YW4sIEUuIFMuPC9hdXRob3I+PGF1dGhvcj5TaXQsIEYuIFkuPC9hdXRob3I+PGF1dGhvcj5MZWUs IEsuPC9hdXRob3I+PGF1dGhvcj5NaWFvLCBYLjwvYXV0aG9yPjxhdXRob3I+WXVhbiwgWi48L2F1 dGhvcj48YXV0aG9yPldhbmcsIFcuPC9hdXRob3I+PGF1dGhvcj5OaWNob2xscywgSi4gTS48L2F1 dGhvcj48YXV0aG9yPldvbmcsIEsuIEsuPC9hdXRob3I+PGF1dGhvcj5HYXJjaWEtQmFyY2Vsbywg TS48L2F1dGhvcj48YXV0aG9yPkx1aSwgVi4gQy48L2F1dGhvcj48YXV0aG9yPlRhbSwgUC4gSy48 L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50 IG9mIFN1cmdlcnksIFVuaXZlcnNpdHkgb2YgSG9uZyBLb25nLCBQb2tmdWxhbSwgSG9uZyBLb25n LCBTQVIsIENoaW5hLCBhbmQgRGVwYXJ0bWVudCBvZiBQZWRpYXRyaWMgU3VyZ2VyeSwgVGhlIFNl Y29uZCBBZmZpbGlhdGVkIEhvc3BpdGFsIG9mIENoaW5hIE1lZGljYWwgVW5pdmVyc2l0eSwgU2hl bnlhbmcsIENoaW5hLiBlbmdhbkBoa3VjYy5oa3UuaGs8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0 aXRsZT5JbXBsaWNhdGlvbnMgb2YgZW5kb2NyaW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5k b3RoZWxpYWwgZ3Jvd3RoIGZhY3Rvci9wcm9raW5ldGljaW4tMSBzaWduYWxpbmcgaW4gaHVtYW4g bmV1cm9ibGFzdG9tYSBwcm9ncmVzc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DbGluIENh bmNlciBSZXM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs ZT5DbGluIENhbmNlciBSZXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz44NjgtNzU8 L3BhZ2VzPjx2b2x1bWU+MTM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48ZWRpdGlvbj4yMDA3 LzAyLzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DZWxsIE1vdmVtZW50PC9rZXl3b3Jk PjxrZXl3b3JkPkNlbGwgUHJvbGlmZXJhdGlvbjwva2V5d29yZD48a2V5d29yZD5DaGlsZDwva2V5 d29yZD48a2V5d29yZD5DaGlsZCwgUHJlc2Nob29sPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vhc2Ug UHJvZ3Jlc3Npb248L2tleXdvcmQ+PGtleXdvcmQ+RW5kb2NyaW5lIEdsYW5kcy8qbWV0YWJvbGlz bTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+KkdlbmUgRXhwcmVz c2lvbiBSZWd1bGF0aW9uLCBOZW9wbGFzdGljPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5 d29yZD48a2V5d29yZD5JbmZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5 d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+PGtleXdvcmQ+TmV1cm9ibGFzdG9t YS8qbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UmV2ZXJzZSBUcmFuc2Ny aXB0YXNlIFBvbHltZXJhc2UgQ2hhaW4gUmVhY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+KlNpZ25h bCBUcmFuc2R1Y3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jv d3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2ZWQvKm1ldGFib2xpc208L2tleXdvcmQ+ PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYiAx PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTA3OC0wNDMyIChQcmludCkmI3hEOzEw NzgtMDQzMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTcyODk4Nzk8L2FjY2Vzc2lv bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv di9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1D aXRhdGlvbiZhbXA7bGlzdF91aWRzPTE3Mjg5ODc5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMy8zLzg2OCBbcGlpXSYjeEQ7MTAuMTE1OC8xMDc4 LTA0MzIuQ0NSLTA2LTIxNzY8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8 L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5OZ2FuPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj TnVtPjExMDwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTEwPC9yZWMtbnVtYmVyPjxmb3Jl aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQzeGRl cnRheHZkZjJ0Ij4xMTA8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5h bCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPk5n YW4sIEUuIFMuPC9hdXRob3I+PGF1dGhvcj5TaXQsIEYuIFkuPC9hdXRob3I+PGF1dGhvcj5MZWUs IEsuPC9hdXRob3I+PGF1dGhvcj5NaWFvLCBYLjwvYXV0aG9yPjxhdXRob3I+WXVhbiwgWi48L2F1 dGhvcj48YXV0aG9yPldhbmcsIFcuPC9hdXRob3I+PGF1dGhvcj5OaWNob2xscywgSi4gTS48L2F1 dGhvcj48YXV0aG9yPldvbmcsIEsuIEsuPC9hdXRob3I+PGF1dGhvcj5HYXJjaWEtQmFyY2Vsbywg TS48L2F1dGhvcj48YXV0aG9yPkx1aSwgVi4gQy48L2F1dGhvcj48YXV0aG9yPlRhbSwgUC4gSy48 L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PGF1dGgtYWRkcmVzcz5EZXBhcnRtZW50 IG9mIFN1cmdlcnksIFVuaXZlcnNpdHkgb2YgSG9uZyBLb25nLCBQb2tmdWxhbSwgSG9uZyBLb25n LCBTQVIsIENoaW5hLCBhbmQgRGVwYXJ0bWVudCBvZiBQZWRpYXRyaWMgU3VyZ2VyeSwgVGhlIFNl Y29uZCBBZmZpbGlhdGVkIEhvc3BpdGFsIG9mIENoaW5hIE1lZGljYWwgVW5pdmVyc2l0eSwgU2hl bnlhbmcsIENoaW5hLiBlbmdhbkBoa3VjYy5oa3UuaGs8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0 aXRsZT5JbXBsaWNhdGlvbnMgb2YgZW5kb2NyaW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5k b3RoZWxpYWwgZ3Jvd3RoIGZhY3Rvci9wcm9raW5ldGljaW4tMSBzaWduYWxpbmcgaW4gaHVtYW4g bmV1cm9ibGFzdG9tYSBwcm9ncmVzc2lvbjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5DbGluIENh bmNlciBSZXM8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRs ZT5DbGluIENhbmNlciBSZXM8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxwYWdlcz44NjgtNzU8 L3BhZ2VzPjx2b2x1bWU+MTM8L3ZvbHVtZT48bnVtYmVyPjM8L251bWJlcj48ZWRpdGlvbj4yMDA3 LzAyLzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DZWxsIE1vdmVtZW50PC9rZXl3b3Jk PjxrZXl3b3JkPkNlbGwgUHJvbGlmZXJhdGlvbjwva2V5d29yZD48a2V5d29yZD5DaGlsZDwva2V5 d29yZD48a2V5d29yZD5DaGlsZCwgUHJlc2Nob29sPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2Vhc2Ug UHJvZ3Jlc3Npb248L2tleXdvcmQ+PGtleXdvcmQ+RW5kb2NyaW5lIEdsYW5kcy8qbWV0YWJvbGlz bTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+KkdlbmUgRXhwcmVz c2lvbiBSZWd1bGF0aW9uLCBOZW9wbGFzdGljPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5 d29yZD48a2V5d29yZD5JbmZhbnQ8L2tleXdvcmQ+PGtleXdvcmQ+TWFsZTwva2V5d29yZD48a2V5 d29yZD5OZW9wbGFzbSBJbnZhc2l2ZW5lc3M8L2tleXdvcmQ+PGtleXdvcmQ+TmV1cm9ibGFzdG9t YS8qbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+UmV2ZXJzZSBUcmFuc2Ny aXB0YXNlIFBvbHltZXJhc2UgQ2hhaW4gUmVhY3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+KlNpZ25h bCBUcmFuc2R1Y3Rpb248L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jv d3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2ZWQvKm1ldGFib2xpc208L2tleXdvcmQ+ PC9rZXl3b3Jkcz48ZGF0ZXM+PHllYXI+MjAwNzwveWVhcj48cHViLWRhdGVzPjxkYXRlPkZlYiAx PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTA3OC0wNDMyIChQcmludCkmI3hEOzEw NzgtMDQzMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTcyODk4Nzk8L2FjY2Vzc2lv bi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNiaS5ubG0ubmloLmdv di9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1lZCZhbXA7ZG9wdD1D aXRhdGlvbiZhbXA7bGlzdF91aWRzPTE3Mjg5ODc5PC91cmw+PC9yZWxhdGVkLXVybHM+PC91cmxz PjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMy8zLzg2OCBbcGlpXSYjeEQ7MTAuMTE1OC8xMDc4 LTA0MzIuQ0NSLTA2LTIxNzY8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxsYW5ndWFnZT5lbmc8 L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG== ADDIN EN.CITE.DATA (Ngan, et al., 2007b)
	Prokineticin-1 derived from islet and/or pancreatic stellate cells act through its receptor on endothelial cells to increase angiogenesis in pancreatic disease
	Prokineticin-2 play a role in pathophysiological in human tumors and inflammatory disorders	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5aaG9uZzwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT4xNzM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3MzwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTczPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5a aG9uZywgQy48L2F1dGhvcj48YXV0aG9yPlF1LCBYLjwvYXV0aG9yPjxhdXRob3I+VGFuLCBNLjwv YXV0aG9yPjxhdXRob3I+TWVuZywgWS4gRy48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmEsIE4uPC9h dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+R2VuZW50ZWNoLCBJ bmMsIDEgRE5BIFdheSwgU291dGggU2FuIEZyYW5jaXNjbywgQ2FsaWZvcm5pYSA5NDA4MCwgVVNB LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkNoYXJhY3Rlcml6YXRpb24gYW5kIHJlZ3Vs YXRpb24gb2YgYnY4IGluIGh1bWFuIGJsb29kIGNlbGxzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl PkNsaW4gQ2FuY2VyIFJlczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm dWxsLXRpdGxlPkNsaW4gQ2FuY2VyIFJlczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz PjI2NzUtODQ8L3BhZ2VzPjx2b2x1bWU+MTU8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZWRp dGlvbj4yMDA5LzA0LzAyPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DZWxsIE1vdmVtZW50 L2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNlbGxzLCBDdWx0dXJl ZDwva2V5d29yZD48a2V5d29yZD5DaGVtb3RheGlzL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9r ZXl3b3JkPjxrZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgSG9ybW9uZXMvKmJsb29kL21ldGFib2xp c20vcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkdyYW51bG9jeXRlIENvbG9ueS1TdGlt dWxhdGluZyBGYWN0b3IvbWV0YWJvbGlzbS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+ R3JhbnVsb2N5dGUtTWFjcm9waGFnZSBDb2xvbnktU3RpbXVsYXRpbmcgRmFjdG9yL21ldGFib2xp c20vcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29y ZD5MdW5nIE5lb3BsYXNtcy9tZXRhYm9saXNtL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5N b25vY3l0ZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+TmV1cm9wZXB0aWRlcy8qYmxv b2QvbWV0YWJvbGlzbS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TmV1dHJvcGhpbHMv ZHJ1ZyBlZmZlY3RzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgRy1Q cm90ZWluLUNvdXBsZWQvYWdvbmlzdHMvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5VcC1S ZWd1bGF0aW9uL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRvdGhl bGlhbCBHcm93dGggRmFjdG9yIFJlY2VwdG9yLTEvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29y ZD5WYXNjdWxhciBFbmRvdGhlbGlhbCBHcm93dGggRmFjdG9yIFJlY2VwdG9yLTIvbWV0YWJvbGlz bTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+ PGRhdGU+QXByIDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTA3OC0wNDMyIChQ cmludCkmI3hEOzEwNzgtMDQzMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTkzMzY1 MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi aS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1l ZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTE5MzM2NTE5PC91cmw+PC9yZWxhdGVk LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMDc4LTA0MzIuQ0NSLTA4LTE5 NTQgW3BpaV0mI3hEOzEwLjExNTgvMTA3OC0wNDMyLkNDUi0wOC0xOTU0PC9lbGVjdHJvbmljLXJl c291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmRO b3RlPgB= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5aaG9uZzwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT4xNzM8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3MzwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTczPC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5a aG9uZywgQy48L2F1dGhvcj48YXV0aG9yPlF1LCBYLjwvYXV0aG9yPjxhdXRob3I+VGFuLCBNLjwv YXV0aG9yPjxhdXRob3I+TWVuZywgWS4gRy48L2F1dGhvcj48YXV0aG9yPkZlcnJhcmEsIE4uPC9h dXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+R2VuZW50ZWNoLCBJ bmMsIDEgRE5BIFdheSwgU291dGggU2FuIEZyYW5jaXNjbywgQ2FsaWZvcm5pYSA5NDA4MCwgVVNB LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPkNoYXJhY3Rlcml6YXRpb24gYW5kIHJlZ3Vs YXRpb24gb2YgYnY4IGluIGh1bWFuIGJsb29kIGNlbGxzPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxl PkNsaW4gQ2FuY2VyIFJlczwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm dWxsLXRpdGxlPkNsaW4gQ2FuY2VyIFJlczwvZnVsbC10aXRsZT48L3BlcmlvZGljYWw+PHBhZ2Vz PjI2NzUtODQ8L3BhZ2VzPjx2b2x1bWU+MTU8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZWRp dGlvbj4yMDA5LzA0LzAyPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5DZWxsIE1vdmVtZW50 L2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNlbGxzLCBDdWx0dXJl ZDwva2V5d29yZD48a2V5d29yZD5DaGVtb3RheGlzL2RydWcgZWZmZWN0cy9waHlzaW9sb2d5PC9r ZXl3b3JkPjxrZXl3b3JkPkdhc3Ryb2ludGVzdGluYWwgSG9ybW9uZXMvKmJsb29kL21ldGFib2xp c20vcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkdyYW51bG9jeXRlIENvbG9ueS1TdGlt dWxhdGluZyBGYWN0b3IvbWV0YWJvbGlzbS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+ R3JhbnVsb2N5dGUtTWFjcm9waGFnZSBDb2xvbnktU3RpbXVsYXRpbmcgRmFjdG9yL21ldGFib2xp c20vcGhhcm1hY29sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29y ZD5MdW5nIE5lb3BsYXNtcy9tZXRhYm9saXNtL3BhdGhvbG9neTwva2V5d29yZD48a2V5d29yZD5N b25vY3l0ZXMvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+TmV1cm9wZXB0aWRlcy8qYmxv b2QvbWV0YWJvbGlzbS9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TmV1dHJvcGhpbHMv ZHJ1ZyBlZmZlY3RzLyptZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJlY2VwdG9ycywgRy1Q cm90ZWluLUNvdXBsZWQvYWdvbmlzdHMvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29yZD5VcC1S ZWd1bGF0aW9uL2RydWcgZWZmZWN0czwva2V5d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRvdGhl bGlhbCBHcm93dGggRmFjdG9yIFJlY2VwdG9yLTEvbWV0YWJvbGlzbTwva2V5d29yZD48a2V5d29y ZD5WYXNjdWxhciBFbmRvdGhlbGlhbCBHcm93dGggRmFjdG9yIFJlY2VwdG9yLTIvbWV0YWJvbGlz bTwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjxwdWItZGF0ZXM+ PGRhdGU+QXByIDE1PC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTA3OC0wNDMyIChQ cmludCkmI3hEOzEwNzgtMDQzMiAoTGlua2luZyk8L2lzYm4+PGFjY2Vzc2lvbi1udW0+MTkzMzY1 MTk8L2FjY2Vzc2lvbi1udW0+PHVybHM+PHJlbGF0ZWQtdXJscz48dXJsPmh0dHA6Ly93d3cubmNi aS5ubG0ubmloLmdvdi9lbnRyZXovcXVlcnkuZmNnaT9jbWQ9UmV0cmlldmUmYW1wO2RiPVB1Yk1l ZCZhbXA7ZG9wdD1DaXRhdGlvbiZhbXA7bGlzdF91aWRzPTE5MzM2NTE5PC91cmw+PC9yZWxhdGVk LXVybHM+PC91cmxzPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMDc4LTA0MzIuQ0NSLTA4LTE5 NTQgW3BpaV0mI3hEOzEwLjExNTgvMTA3OC0wNDMyLkNDUi0wOC0xOTU0PC9lbGVjdHJvbmljLXJl c291cmNlLW51bT48bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmRO b3RlPgB= ADDIN EN.CITE.DATA (Zhong, et al., 2009)
	Prokineticin-1 is significantly increased in papillary thyroid cancer and its expression in papillary thyroid cancer is related to BRAF oncogen	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXNxdWFsaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+ PFJlY051bT4xNzQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3NDwvcmVjLW51bWJlcj48 Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0 M3hkZXJ0YXh2ZGYydCI+MTc0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv cj5QYXNxdWFsaSwgRC48L2F1dGhvcj48YXV0aG9yPlNhbnRvcm8sIEEuPC9hdXRob3I+PGF1dGhv cj5CdWZvLCBQLjwvYXV0aG9yPjxhdXRob3I+Q29uem8sIEcuPC9hdXRob3I+PGF1dGhvcj5EZWVy eSwgVy4gSi48L2F1dGhvcj48YXV0aG9yPlJlbnp1bGxvLCBBLjwvYXV0aG9yPjxhdXRob3I+QWNj YXJkbywgRy48L2F1dGhvcj48YXV0aG9yPlNhY2NvLCBWLjwvYXV0aG9yPjxhdXRob3I+QmVsbGFz dGVsbGEsIEEuPC9hdXRob3I+PGF1dGhvcj5QYW5ub25lLCBHLjwvYXV0aG9yPjwvYXV0aG9ycz48 L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4 cGVyaW1lbnRhbCBNZWRpY2luZSBhbmQgU3VyZ2VyeSwgRW5kb2NyaW5lIFVuaXQsIFNlY29uZCBV bml2ZXJzaXR5IG9mIE5hcGxlcywgTmFwbGVzLCBJdGFseS4gZGFuaWVsYS5wYXNxdWFsaUB1bmlu YTIuaXQ8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5VcHJlZ3VsYXRpb24gb2YgZW5kb2Ny aW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciBpbiBw YXBpbGxhcnkgdGh5cm9pZCBjYW5jZXJzIGRpc3BsYXlpbmcgaW5maWx0cmF0aXZlIHBhdHRlcm5z LCBseW1waCBub2RlIG1ldGFzdGFzZXMsIGFuZCBCUkFGIG11dGF0aW9uPC90aXRsZT48c2Vjb25k YXJ5LXRpdGxlPlRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48 ZnVsbC10aXRsZT5UaHlyb2lkPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MzkxLTk8 L3BhZ2VzPjx2b2x1bWU+MjE8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZWRpdGlvbj4yMDEx LzAzLzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5L2dlbmV0aWNzL21l dGFib2xpc20vcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNlbGwgTGluZTwva2V5d29yZD48 a2V5d29yZD5DZWxsIExpbmUsIFR1bW9yPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y ZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLypiaW9zeW50aGVzaXM8L2tleXdv cmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lz PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tl eXdvcmQ+PGtleXdvcmQ+TmV1cm9wZXB0aWRlcy9iaW9zeW50aGVzaXM8L2tleXdvcmQ+PGtleXdv cmQ+UHJvdG8tT25jb2dlbmUgUHJvdGVpbnMgQi1yYWYvKmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3 b3JkPlRoeXJvaWQgTmVvcGxhc21zL2dlbmV0aWNzL21ldGFib2xpc20vcGF0aG9sb2d5PC9rZXl3 b3JkPjxrZXl3b3JkPlVwLVJlZ3VsYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5k b3RoZWxpYWwgR3Jvd3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2ZWQvKmJpb3N5bnRo ZXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0 ZXM+PGRhdGU+QXByPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTU1Ny05MDc3IChF bGVjdHJvbmljKSYjeEQ7MTA1MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4y MTM4NTA4MTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3 dy5uY2JpLm5sbS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9 UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MjEzODUwODE8L3VybD48L3Jl bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwODkvdGh5LjIw MTAuMDE2ODwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+ PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5QYXNxdWFsaTwvQXV0aG9yPjxZZWFyPjIwMTE8L1llYXI+ PFJlY051bT4xNzQ8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3NDwvcmVjLW51bWJlcj48 Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0 M3hkZXJ0YXh2ZGYydCI+MTc0PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9Ikpv dXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhv cj5QYXNxdWFsaSwgRC48L2F1dGhvcj48YXV0aG9yPlNhbnRvcm8sIEEuPC9hdXRob3I+PGF1dGhv cj5CdWZvLCBQLjwvYXV0aG9yPjxhdXRob3I+Q29uem8sIEcuPC9hdXRob3I+PGF1dGhvcj5EZWVy eSwgVy4gSi48L2F1dGhvcj48YXV0aG9yPlJlbnp1bGxvLCBBLjwvYXV0aG9yPjxhdXRob3I+QWNj YXJkbywgRy48L2F1dGhvcj48YXV0aG9yPlNhY2NvLCBWLjwvYXV0aG9yPjxhdXRob3I+QmVsbGFz dGVsbGEsIEEuPC9hdXRob3I+PGF1dGhvcj5QYW5ub25lLCBHLjwvYXV0aG9yPjwvYXV0aG9ycz48 L2NvbnRyaWJ1dG9ycz48YXV0aC1hZGRyZXNzPkRlcGFydG1lbnQgb2YgQ2xpbmljYWwgYW5kIEV4 cGVyaW1lbnRhbCBNZWRpY2luZSBhbmQgU3VyZ2VyeSwgRW5kb2NyaW5lIFVuaXQsIFNlY29uZCBV bml2ZXJzaXR5IG9mIE5hcGxlcywgTmFwbGVzLCBJdGFseS4gZGFuaWVsYS5wYXNxdWFsaUB1bmlu YTIuaXQ8L2F1dGgtYWRkcmVzcz48dGl0bGVzPjx0aXRsZT5VcHJlZ3VsYXRpb24gb2YgZW5kb2Ny aW5lIGdsYW5kLWRlcml2ZWQgdmFzY3VsYXIgZW5kb3RoZWxpYWwgZ3Jvd3RoIGZhY3RvciBpbiBw YXBpbGxhcnkgdGh5cm9pZCBjYW5jZXJzIGRpc3BsYXlpbmcgaW5maWx0cmF0aXZlIHBhdHRlcm5z LCBseW1waCBub2RlIG1ldGFzdGFzZXMsIGFuZCBCUkFGIG11dGF0aW9uPC90aXRsZT48c2Vjb25k YXJ5LXRpdGxlPlRoeXJvaWQ8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48 ZnVsbC10aXRsZT5UaHlyb2lkPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNhbD48cGFnZXM+MzkxLTk8 L3BhZ2VzPjx2b2x1bWU+MjE8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZWRpdGlvbj4yMDEx LzAzLzEwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZHVsdDwva2V5d29yZD48a2V5d29y ZD5BZ2VkPC9rZXl3b3JkPjxrZXl3b3JkPkNhcmNpbm9tYSwgUGFwaWxsYXJ5L2dlbmV0aWNzL21l dGFib2xpc20vcGF0aG9sb2d5PC9rZXl3b3JkPjxrZXl3b3JkPkNlbGwgTGluZTwva2V5d29yZD48 a2V5d29yZD5DZWxsIExpbmUsIFR1bW9yPC9rZXl3b3JkPjxrZXl3b3JkPkZlbWFsZTwva2V5d29y ZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLypiaW9zeW50aGVzaXM8L2tleXdv cmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3b3JkPjxrZXl3b3JkPkx5bXBoYXRpYyBNZXRhc3Rhc2lz PC9rZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWlkZGxlIEFnZWQ8L2tl eXdvcmQ+PGtleXdvcmQ+TmV1cm9wZXB0aWRlcy9iaW9zeW50aGVzaXM8L2tleXdvcmQ+PGtleXdv cmQ+UHJvdG8tT25jb2dlbmUgUHJvdGVpbnMgQi1yYWYvKmdlbmV0aWNzPC9rZXl3b3JkPjxrZXl3 b3JkPlRoeXJvaWQgTmVvcGxhc21zL2dlbmV0aWNzL21ldGFib2xpc20vcGF0aG9sb2d5PC9rZXl3 b3JkPjxrZXl3b3JkPlVwLVJlZ3VsYXRpb248L2tleXdvcmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5k b3RoZWxpYWwgR3Jvd3RoIEZhY3RvciwgRW5kb2NyaW5lLUdsYW5kLURlcml2ZWQvKmJpb3N5bnRo ZXNpczwva2V5d29yZD48L2tleXdvcmRzPjxkYXRlcz48eWVhcj4yMDExPC95ZWFyPjxwdWItZGF0 ZXM+PGRhdGU+QXByPC9kYXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTU1Ny05MDc3IChF bGVjdHJvbmljKSYjeEQ7MTA1MC03MjU2IChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4y MTM4NTA4MTwvYWNjZXNzaW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3 dy5uY2JpLm5sbS5uaWguZ292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9 UHViTWVkJmFtcDtkb3B0PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MjEzODUwODE8L3VybD48L3Jl bGF0ZWQtdXJscz48L3VybHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwODkvdGh5LjIw MTAuMDE2ODwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+ PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5= ADDIN EN.CITE.DATA (Pasquali, et al., 2011)
Vascular	Prokineticin-2 is involved in immune and inflammatory response at abdominal aortic aneurysms site	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaG9rZTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT4xNzU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3NTwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTc1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5D aG9rZSwgRS48L2F1dGhvcj48YXV0aG9yPkNvY2tlcmlsbCwgRy4gVy48L2F1dGhvcj48YXV0aG9y PkxhaW5nLCBLLjwvYXV0aG9yPjxhdXRob3I+RGF3c29uLCBKLjwvYXV0aG9yPjxhdXRob3I+V2ls c29uLCBXLiBSLjwvYXV0aG9yPjxhdXRob3I+TG9mdHVzLCBJLiBNLjwvYXV0aG9yPjxhdXRob3I+ VGhvbXBzb24sIE0uIE0uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk ZHJlc3M+U3QgR2VvcmdlJmFwb3M7cyBWYXNjdWxhciBJbnN0aXR1dGUsIFN0IEdlb3JnZSZhcG9z O3MgSG9zcGl0YWwsIEJsYWNrc2hhdyBSb2FkLCBUb290aW5nLCBMb25kb24gU1cxNyAwUkUsIFVL LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPldob2xlIGdlbm9tZS1leHByZXNzaW9uIHBy b2ZpbGluZyByZXZlYWxzIGEgcm9sZSBmb3IgaW1tdW5lIGFuZCBpbmZsYW1tYXRvcnkgcmVzcG9u c2UgaW4gYWJkb21pbmFsIGFvcnRpYyBhbmV1cnlzbSBydXB0dXJlPC90aXRsZT48c2Vjb25kYXJ5 LXRpdGxlPkV1ciBKIFZhc2MgRW5kb3Zhc2MgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBKIFZhc2MgRW5kb3Zhc2MgU3VyZzwvZnVsbC10 aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjMwNS0xMDwvcGFnZXM+PHZvbHVtZT4zNzwvdm9sdW1l PjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDgvMTIvMzA8L2VkaXRpb24+PGtleXdvcmRz PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdv cmQ+PGtleXdvcmQ+QW9ydGljIEFuZXVyeXNtLCBBYmRvbWluYWwvKmdlbmV0aWNzL3BhdGhvbG9n eTwva2V5d29yZD48a2V5d29yZD5Bb3J0aWMgUnVwdHVyZS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtl eXdvcmQ+Q3ljbG9veHlnZW5hc2UgMi8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+Q3l0b2tp bmVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5FLVNlbGVjdGluLypnZW5ldGljczwva2V5 d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLypnZW5ldGljczwva2V5d29y ZD48a2V5d29yZD4qR2VuZSBFeHByZXNzaW9uIFByb2ZpbGluZzwva2V5d29yZD48a2V5d29yZD5H ZW5vbWUsIEh1bWFuPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5J bmZsYW1tYXRpb24vZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+TWljcm9hcnJheSBBbmFseXNp czwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZXVyb3Bl cHRpZGVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5STkEsIE1lc3Nlbmdlci9tZXRhYm9s aXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJhbnNjcmlwdGFzZSBQb2x5bWVyYXNlIENo YWluIFJlYWN0aW9uPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDk8L3llYXI+ PHB1Yi1kYXRlcz48ZGF0ZT5NYXI8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMy LTIxNjUgKEVsZWN0cm9uaWMpJiN4RDsxMDc4LTU4ODQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np b24tbnVtPjE5MTExNDgxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZl JmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xOTExMTQ4MTwv dXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+UzEwNzgt NTg4NCgwOCkwMDYyNi02IFtwaWldJiN4RDsxMC4xMDE2L2ouZWp2cy4yMDA4LjExLjAxNzwvZWxl Y3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D aXRlPjwvRW5kTm90ZT4A ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DaG9rZTwvQXV0aG9yPjxZZWFyPjIwMDk8L1llYXI+PFJl Y051bT4xNzU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE3NTwvcmVjLW51bWJlcj48Zm9y ZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hk ZXJ0YXh2ZGYydCI+MTc1PC9rZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJu YWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5D aG9rZSwgRS48L2F1dGhvcj48YXV0aG9yPkNvY2tlcmlsbCwgRy4gVy48L2F1dGhvcj48YXV0aG9y PkxhaW5nLCBLLjwvYXV0aG9yPjxhdXRob3I+RGF3c29uLCBKLjwvYXV0aG9yPjxhdXRob3I+V2ls c29uLCBXLiBSLjwvYXV0aG9yPjxhdXRob3I+TG9mdHVzLCBJLiBNLjwvYXV0aG9yPjxhdXRob3I+ VGhvbXBzb24sIE0uIE0uPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjxhdXRoLWFk ZHJlc3M+U3QgR2VvcmdlJmFwb3M7cyBWYXNjdWxhciBJbnN0aXR1dGUsIFN0IEdlb3JnZSZhcG9z O3MgSG9zcGl0YWwsIEJsYWNrc2hhdyBSb2FkLCBUb290aW5nLCBMb25kb24gU1cxNyAwUkUsIFVL LjwvYXV0aC1hZGRyZXNzPjx0aXRsZXM+PHRpdGxlPldob2xlIGdlbm9tZS1leHByZXNzaW9uIHBy b2ZpbGluZyByZXZlYWxzIGEgcm9sZSBmb3IgaW1tdW5lIGFuZCBpbmZsYW1tYXRvcnkgcmVzcG9u c2UgaW4gYWJkb21pbmFsIGFvcnRpYyBhbmV1cnlzbSBydXB0dXJlPC90aXRsZT48c2Vjb25kYXJ5 LXRpdGxlPkV1ciBKIFZhc2MgRW5kb3Zhc2MgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkV1ciBKIFZhc2MgRW5kb3Zhc2MgU3VyZzwvZnVsbC10 aXRsZT48L3BlcmlvZGljYWw+PHBhZ2VzPjMwNS0xMDwvcGFnZXM+PHZvbHVtZT4zNzwvdm9sdW1l PjxudW1iZXI+MzwvbnVtYmVyPjxlZGl0aW9uPjIwMDgvMTIvMzA8L2VkaXRpb24+PGtleXdvcmRz PjxrZXl3b3JkPkFnZWQ8L2tleXdvcmQ+PGtleXdvcmQ+QWdlZCwgODAgYW5kIG92ZXI8L2tleXdv cmQ+PGtleXdvcmQ+QW9ydGljIEFuZXVyeXNtLCBBYmRvbWluYWwvKmdlbmV0aWNzL3BhdGhvbG9n eTwva2V5d29yZD48a2V5d29yZD5Bb3J0aWMgUnVwdHVyZS8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtl eXdvcmQ+Q3ljbG9veHlnZW5hc2UgMi8qZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+Q3l0b2tp bmVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5FLVNlbGVjdGluLypnZW5ldGljczwva2V5 d29yZD48a2V5d29yZD5HYXN0cm9pbnRlc3RpbmFsIEhvcm1vbmVzLypnZW5ldGljczwva2V5d29y ZD48a2V5d29yZD4qR2VuZSBFeHByZXNzaW9uIFByb2ZpbGluZzwva2V5d29yZD48a2V5d29yZD5H ZW5vbWUsIEh1bWFuPC9rZXl3b3JkPjxrZXl3b3JkPkh1bWFuczwva2V5d29yZD48a2V5d29yZD5J bmZsYW1tYXRpb24vZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+TWljcm9hcnJheSBBbmFseXNp czwva2V5d29yZD48a2V5d29yZD5NaWRkbGUgQWdlZDwva2V5d29yZD48a2V5d29yZD5OZXVyb3Bl cHRpZGVzLypnZW5ldGljczwva2V5d29yZD48a2V5d29yZD5STkEsIE1lc3Nlbmdlci9tZXRhYm9s aXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJldmVyc2UgVHJhbnNjcmlwdGFzZSBQb2x5bWVyYXNlIENo YWluIFJlYWN0aW9uPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDk8L3llYXI+ PHB1Yi1kYXRlcz48ZGF0ZT5NYXI8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMy LTIxNjUgKEVsZWN0cm9uaWMpJiN4RDsxMDc4LTU4ODQgKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Np b24tbnVtPjE5MTExNDgxPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5o dHRwOi8vd3d3Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZl JmFtcDtkYj1QdWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xOTExMTQ4MTwv dXJsPjwvcmVsYXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+UzEwNzgt NTg4NCgwOCkwMDYyNi02IFtwaWldJiN4RDsxMC4xMDE2L2ouZWp2cy4yMDA4LjExLjAxNzwvZWxl Y3Ryb25pYy1yZXNvdXJjZS1udW0+PGxhbmd1YWdlPmVuZzwvbGFuZ3VhZ2U+PC9yZWNvcmQ+PC9D aXRlPjwvRW5kTm90ZT4A ADDIN EN.CITE.DATA (Choke, et al., 2009)
Inflammation	Prokineticin-1 was found in the controls in the patients with temporomandibular joint disorders	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IZXJyPC9BdXRob3I+PFJlY051bT4xNzY8L1JlY051bT48 cmVjb3JkPjxyZWMtbnVtYmVyPjE3NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw PSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hkZXJ0YXh2ZGYydCI+MTc2PC9r ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IZXJyLCBNLiBNLjwvYXV0aG9y PjxhdXRob3I+RnJpZXMsIEsuIE0uPC9hdXRob3I+PGF1dGhvcj5VcHRvbiwgTC4gRy48L2F1dGhv cj48YXV0aG9yPkVkc2JlcmcsIEwuIEUuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3Jz PjxhdXRoLWFkZHJlc3M+TmF0dXJhbCBTY2llbmNlcyBEZXBhcnRtZW50LCBEYWVtZW4gQ29sbGVn ZSwgQW1oZXJzdCwgTlksIFVTQS4gTWVnYW5fSGVyckB1cm1jLnJvY2hlc3Rlci5lZHU8L2F1dGgt YWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb3RlbnRpYWwgYmlvbWFya2VycyBvZiB0ZW1wb3JvbWFu ZGlidWxhciBqb2ludCBkaXNvcmRlcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBPcmFsIE1h eGlsbG9mYWMgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs LXRpdGxlPkogT3JhbCBNYXhpbGxvZmFjIFN1cmc8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxw YWdlcz40MS03PC9wYWdlcz48dm9sdW1lPjY5PC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGVk aXRpb24+MjAxMC8xMi8xODwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWN0aXZpbnMvYW5h bHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVs dDwva2V5d29yZD48a2V5d29yZD5CaW9sb2dpY2FsIE1hcmtlcnMvKmFuYWx5c2lzPC9rZXl3b3Jk PjxrZXl3b3JkPkNhcmJvbmljIEFuaHlkcmFzZXMvYW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+ Q2FzZS1Db250cm9sIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2hlbW9raW5lIENDTDIxL2Fu YWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2xvY2F0aW9ucy9kaWFnbm9zaXMvbWV0YWJvbGlz bTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3 b3JkPjxrZXl3b3JkPkluc3VsaW4tTGlrZSBHcm93dGggRmFjdG9yIElJL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPk1hdHJpeCBNZXRhbGxvcHJvdGVpbmFzZSAxNi9hbmFseXNpczwva2V5d29y ZD48a2V5d29yZD5QYXJhY2VudGVzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGVyb3hpcmVkb3hpbnMv YW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGlsb3QgUHJvamVjdHM8L2tleXdvcmQ+PGtleXdv cmQ+UHJvdGVpbiBBcnJheSBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5Qcm90ZW9tZS8qYW5h bHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBDQ1IxMC9hbmFseXNpczwva2V5d29y ZD48a2V5d29yZD5TeW5vdmlhbCBGbHVpZC9jaGVtaXN0cnk8L2tleXdvcmQ+PGtleXdvcmQ+VGVt cG9yb21hbmRpYnVsYXIgSm9pbnQgRGlzYy9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VGVt cG9yb21hbmRpYnVsYXIgSm9pbnQgRGlzb3JkZXJzLypkaWFnbm9zaXMvbWV0YWJvbGlzbTwva2V5 d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRvdGhlbGlhbCBHcm93dGggRmFjdG9yLCBFbmRvY3Jp bmUtR2xhbmQtRGVyaXZlZC9hbmFseXNpczwva2V5d29yZD48a2V5d29yZD5Zb3VuZyBBZHVsdDwv a2V5d29yZD48a2V5d29yZD5hbHBoYS1HbG9iaW5zL2FuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3Jk PmJldGEtR2xvYmlucy9hbmFseXNpczwva2V5d29yZD48a2V5d29yZD5nYW1tYS1HbG9iaW5zL2Fu YWx5c2lzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9k YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUzMS01MDUzIChFbGVjdHJvbmljKSYjeEQ7 MDI3OC0yMzkxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTE2MzM4MTwvYWNjZXNz aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu Z292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0 PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MjExNjMzODE8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPlMwMjc4LTIzOTEoMTApMDA1NTctNCBbcGlpXSYj eEQ7MTAuMTAxNi9qLmpvbXMuMjAxMC4wNS4wMTM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxs YW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+ ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IZXJyPC9BdXRob3I+PFJlY051bT4xNzY8L1JlY051bT48 cmVjb3JkPjxyZWMtbnVtYmVyPjE3NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBw PSJFTiIgZGItaWQ9IjU5MnAyeGE5N3o1dGU4ZWZwOWJwZnh0M3hkZXJ0YXh2ZGYydCI+MTc2PC9r ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj5IZXJyLCBNLiBNLjwvYXV0aG9y PjxhdXRob3I+RnJpZXMsIEsuIE0uPC9hdXRob3I+PGF1dGhvcj5VcHRvbiwgTC4gRy48L2F1dGhv cj48YXV0aG9yPkVkc2JlcmcsIEwuIEUuPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3Jz PjxhdXRoLWFkZHJlc3M+TmF0dXJhbCBTY2llbmNlcyBEZXBhcnRtZW50LCBEYWVtZW4gQ29sbGVn ZSwgQW1oZXJzdCwgTlksIFVTQS4gTWVnYW5fSGVyckB1cm1jLnJvY2hlc3Rlci5lZHU8L2F1dGgt YWRkcmVzcz48dGl0bGVzPjx0aXRsZT5Qb3RlbnRpYWwgYmlvbWFya2VycyBvZiB0ZW1wb3JvbWFu ZGlidWxhciBqb2ludCBkaXNvcmRlcnM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+SiBPcmFsIE1h eGlsbG9mYWMgU3VyZzwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxs LXRpdGxlPkogT3JhbCBNYXhpbGxvZmFjIFN1cmc8L2Z1bGwtdGl0bGU+PC9wZXJpb2RpY2FsPjxw YWdlcz40MS03PC9wYWdlcz48dm9sdW1lPjY5PC92b2x1bWU+PG51bWJlcj4xPC9udW1iZXI+PGVk aXRpb24+MjAxMC8xMi8xODwvZWRpdGlvbj48a2V5d29yZHM+PGtleXdvcmQ+QWN0aXZpbnMvYW5h bHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+QWRvbGVzY2VudDwva2V5d29yZD48a2V5d29yZD5BZHVs dDwva2V5d29yZD48a2V5d29yZD5CaW9sb2dpY2FsIE1hcmtlcnMvKmFuYWx5c2lzPC9rZXl3b3Jk PjxrZXl3b3JkPkNhcmJvbmljIEFuaHlkcmFzZXMvYW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+ Q2FzZS1Db250cm9sIFN0dWRpZXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2hlbW9raW5lIENDTDIxL2Fu YWx5c2lzPC9rZXl3b3JkPjxrZXl3b3JkPkRpc2xvY2F0aW9ucy9kaWFnbm9zaXMvbWV0YWJvbGlz bTwva2V5d29yZD48a2V5d29yZD5GZW1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+SHVtYW5zPC9rZXl3 b3JkPjxrZXl3b3JkPkluc3VsaW4tTGlrZSBHcm93dGggRmFjdG9yIElJL2FuYWx5c2lzPC9rZXl3 b3JkPjxrZXl3b3JkPk1hdHJpeCBNZXRhbGxvcHJvdGVpbmFzZSAxNi9hbmFseXNpczwva2V5d29y ZD48a2V5d29yZD5QYXJhY2VudGVzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGVyb3hpcmVkb3hpbnMv YW5hbHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UGlsb3QgUHJvamVjdHM8L2tleXdvcmQ+PGtleXdv cmQ+UHJvdGVpbiBBcnJheSBBbmFseXNpczwva2V5d29yZD48a2V5d29yZD5Qcm90ZW9tZS8qYW5h bHlzaXM8L2tleXdvcmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBDQ1IxMC9hbmFseXNpczwva2V5d29y ZD48a2V5d29yZD5TeW5vdmlhbCBGbHVpZC9jaGVtaXN0cnk8L2tleXdvcmQ+PGtleXdvcmQ+VGVt cG9yb21hbmRpYnVsYXIgSm9pbnQgRGlzYy9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+VGVt cG9yb21hbmRpYnVsYXIgSm9pbnQgRGlzb3JkZXJzLypkaWFnbm9zaXMvbWV0YWJvbGlzbTwva2V5 d29yZD48a2V5d29yZD5WYXNjdWxhciBFbmRvdGhlbGlhbCBHcm93dGggRmFjdG9yLCBFbmRvY3Jp bmUtR2xhbmQtRGVyaXZlZC9hbmFseXNpczwva2V5d29yZD48a2V5d29yZD5Zb3VuZyBBZHVsdDwv a2V5d29yZD48a2V5d29yZD5hbHBoYS1HbG9iaW5zL2FuYWx5c2lzPC9rZXl3b3JkPjxrZXl3b3Jk PmJldGEtR2xvYmlucy9hbmFseXNpczwva2V5d29yZD48a2V5d29yZD5nYW1tYS1HbG9iaW5zL2Fu YWx5c2lzPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjxwdWItZGF0ZXM+PGRhdGU+SmFuPC9k YXRlPjwvcHViLWRhdGVzPjwvZGF0ZXM+PGlzYm4+MTUzMS01MDUzIChFbGVjdHJvbmljKSYjeEQ7 MDI3OC0yMzkxIChMaW5raW5nKTwvaXNibj48YWNjZXNzaW9uLW51bT4yMTE2MzM4MTwvYWNjZXNz aW9uLW51bT48dXJscz48cmVsYXRlZC11cmxzPjx1cmw+aHR0cDovL3d3dy5uY2JpLm5sbS5uaWgu Z292L2VudHJlei9xdWVyeS5mY2dpP2NtZD1SZXRyaWV2ZSZhbXA7ZGI9UHViTWVkJmFtcDtkb3B0 PUNpdGF0aW9uJmFtcDtsaXN0X3VpZHM9MjExNjMzODE8L3VybD48L3JlbGF0ZWQtdXJscz48L3Vy bHM+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPlMwMjc4LTIzOTEoMTApMDA1NTctNCBbcGlpXSYj eEQ7MTAuMTAxNi9qLmpvbXMuMjAxMC4wNS4wMTM8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjxs YW5ndWFnZT5lbmc8L2xhbmd1YWdlPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+ ADDIN EN.CITE.DATA (Herr, et al.)
Cardiology	Prokineticin-2 and PKR1 were reduced in human end stage failure heart sample	PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5VcmF5YW1hPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48 UmVjTnVtPjEwNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTA3PC9yZWMtbnVtYmVyPjxm b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQz eGRlcnRheHZkZjJ0Ij4xMDc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91 cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y PlVyYXlhbWEsIEsuPC9hdXRob3I+PGF1dGhvcj5HdWlsaW5pLCBDLjwvYXV0aG9yPjxhdXRob3I+ TWVzc2FkZGVxLCBOLjwvYXV0aG9yPjxhdXRob3I+SHUsIEsuPC9hdXRob3I+PGF1dGhvcj5TdGVl bm1hbiwgTS48L2F1dGhvcj48YXV0aG9yPkt1cm9zZSwgSC48L2F1dGhvcj48YXV0aG9yPkVydCwg Ry48L2F1dGhvcj48YXV0aG9yPk5lYmlnaWwsIEMuIEcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29u dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VU1SIDcxNzUvQ05SUy9Vbml2ZXJzaXRlIFN0cmFzYm91 cmcgSSwgRWNvbGUgU3VwZXJpZXVyZSBkZSBCaW90ZWNobm9sb2dpZSBkZSBTdHJhc2JvdXJnLCBC bGQuIFNlYmFzdGllbiBCcmFuZHQgQlAuIDEwNDEzLCBGLTY3NDEyIElsbGtpcmNoLCBGcmFuY2Uu PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+VGhlIHByb2tpbmV0aWNpbiByZWNlcHRvci0x IChHUFI3MykgcHJvbW90ZXMgY2FyZGlvbXlvY3l0ZSBzdXJ2aXZhbCBhbmQgYW5naW9nZW5lc2lz PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkZBU0VCIEo8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5GQVNFQiBKPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh bD48cGFnZXM+Mjk4MC05MzwvcGFnZXM+PHZvbHVtZT4yMTwvdm9sdW1lPjxudW1iZXI+MTE8L251 bWJlcj48ZWRpdGlvbj4yMDA3LzA0LzIwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVu b3ZpcmlkYWUvZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5 d29yZD5BcG9wdG9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBIeXBveGlhPC9rZXl3b3JkPjxr ZXl3b3JkPkNlbGxzLCBDdWx0dXJlZDwva2V5d29yZD48a2V5d29yZD5FbWJyeW8sIE1hbW1hbGlh bjwva2V5d29yZD48a2V5d29yZD5FbmRvdGhlbGl1bSwgVmFzY3VsYXIvY3l0b2xvZ3kvbWV0YWJv bGlzbTwva2V5d29yZD48a2V5d29yZD5HZW5lIFRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SGVh cnQvKnBoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW4gU2l0dSBIeWJyaWRpemF0aW9uPC9r ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWljZTwva2V5d29yZD48a2V5 d29yZD5NaWNlLCBJbmJyZWQgQzU3Qkw8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGlhbCBJbmZh cmN0aW9uL21ldGFib2xpc20vcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3 b3JkPk15b2NhcmRpYWwgSXNjaGVtaWEvbWV0YWJvbGlzbS8qcHJldmVudGlvbiAmYW1wOyBjb250 cm9sPC9rZXl3b3JkPjxrZXl3b3JkPk15b2NhcmRpYWwgUmVwZXJmdXNpb24gSW5qdXJ5L21ldGFi b2xpc20vcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPk15b2NhcmRp dW0vbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY3l0ZXMsIENhcmRp YWMvY3l0b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+Kk5lb3Zhc2N1bGFyaXph dGlvbiwgUGF0aG9sb2dpYzwva2V5d29yZD48a2V5d29yZD5Qcm90by1PbmNvZ2VuZSBQcm90ZWlu cyBjLWFrdC9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSBQcm9iZXM8L2tleXdvcmQ+ PGtleXdvcmQ+Uk5BLCBTbWFsbCBJbnRlcmZlcmluZy9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+UmF0czwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVk L2FudGFnb25pc3RzICZhbXA7IGluaGliaXRvcnMvZ2VuZXRpY3MvKm1ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlL2dlbmV0aWNzL21ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jvd3RoIEZhY3RvciBBLyptZXRhYm9s aXNtPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRl cz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMwLTY4NjAgKEVs ZWN0cm9uaWMpJiN4RDswODkyLTY2MzggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE3 NDQyNzMwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3 Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1Q dWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNzQ0MjczMDwvdXJsPjwvcmVs YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+ZmouMDctODExNmNvbSBb cGlpXSYjeEQ7MTAuMTA5Ni9mai4wNy04MTE2Y29tPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48 bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn== ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5VcmF5YW1hPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48 UmVjTnVtPjEwNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MTA3PC9yZWMtbnVtYmVyPjxm b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iNTkycDJ4YTk3ejV0ZThlZnA5YnBmeHQz eGRlcnRheHZkZjJ0Ij4xMDc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91 cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9y PlVyYXlhbWEsIEsuPC9hdXRob3I+PGF1dGhvcj5HdWlsaW5pLCBDLjwvYXV0aG9yPjxhdXRob3I+ TWVzc2FkZGVxLCBOLjwvYXV0aG9yPjxhdXRob3I+SHUsIEsuPC9hdXRob3I+PGF1dGhvcj5TdGVl bm1hbiwgTS48L2F1dGhvcj48YXV0aG9yPkt1cm9zZSwgSC48L2F1dGhvcj48YXV0aG9yPkVydCwg Ry48L2F1dGhvcj48YXV0aG9yPk5lYmlnaWwsIEMuIEcuPC9hdXRob3I+PC9hdXRob3JzPjwvY29u dHJpYnV0b3JzPjxhdXRoLWFkZHJlc3M+VU1SIDcxNzUvQ05SUy9Vbml2ZXJzaXRlIFN0cmFzYm91 cmcgSSwgRWNvbGUgU3VwZXJpZXVyZSBkZSBCaW90ZWNobm9sb2dpZSBkZSBTdHJhc2JvdXJnLCBC bGQuIFNlYmFzdGllbiBCcmFuZHQgQlAuIDEwNDEzLCBGLTY3NDEyIElsbGtpcmNoLCBGcmFuY2Uu PC9hdXRoLWFkZHJlc3M+PHRpdGxlcz48dGl0bGU+VGhlIHByb2tpbmV0aWNpbiByZWNlcHRvci0x IChHUFI3MykgcHJvbW90ZXMgY2FyZGlvbXlvY3l0ZSBzdXJ2aXZhbCBhbmQgYW5naW9nZW5lc2lz PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkZBU0VCIEo8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5GQVNFQiBKPC9mdWxsLXRpdGxlPjwvcGVyaW9kaWNh bD48cGFnZXM+Mjk4MC05MzwvcGFnZXM+PHZvbHVtZT4yMTwvdm9sdW1lPjxudW1iZXI+MTE8L251 bWJlcj48ZWRpdGlvbj4yMDA3LzA0LzIwPC9lZGl0aW9uPjxrZXl3b3Jkcz48a2V5d29yZD5BZGVu b3ZpcmlkYWUvZ2VuZXRpY3M8L2tleXdvcmQ+PGtleXdvcmQ+QW5pbWFsczwva2V5d29yZD48a2V5 d29yZD5BcG9wdG9zaXM8L2tleXdvcmQ+PGtleXdvcmQ+Q2VsbCBIeXBveGlhPC9rZXl3b3JkPjxr ZXl3b3JkPkNlbGxzLCBDdWx0dXJlZDwva2V5d29yZD48a2V5d29yZD5FbWJyeW8sIE1hbW1hbGlh bjwva2V5d29yZD48a2V5d29yZD5FbmRvdGhlbGl1bSwgVmFzY3VsYXIvY3l0b2xvZ3kvbWV0YWJv bGlzbTwva2V5d29yZD48a2V5d29yZD5HZW5lIFRoZXJhcHk8L2tleXdvcmQ+PGtleXdvcmQ+SGVh cnQvKnBoeXNpb2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+SW4gU2l0dSBIeWJyaWRpemF0aW9uPC9r ZXl3b3JkPjxrZXl3b3JkPk1hbGU8L2tleXdvcmQ+PGtleXdvcmQ+TWljZTwva2V5d29yZD48a2V5 d29yZD5NaWNlLCBJbmJyZWQgQzU3Qkw8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY2FyZGlhbCBJbmZh cmN0aW9uL21ldGFib2xpc20vcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3 b3JkPk15b2NhcmRpYWwgSXNjaGVtaWEvbWV0YWJvbGlzbS8qcHJldmVudGlvbiAmYW1wOyBjb250 cm9sPC9rZXl3b3JkPjxrZXl3b3JkPk15b2NhcmRpYWwgUmVwZXJmdXNpb24gSW5qdXJ5L21ldGFi b2xpc20vcHJldmVudGlvbiAmYW1wOyBjb250cm9sPC9rZXl3b3JkPjxrZXl3b3JkPk15b2NhcmRp dW0vbWV0YWJvbGlzbS9wYXRob2xvZ3k8L2tleXdvcmQ+PGtleXdvcmQ+TXlvY3l0ZXMsIENhcmRp YWMvY3l0b2xvZ3kvKm1ldGFib2xpc208L2tleXdvcmQ+PGtleXdvcmQ+Kk5lb3Zhc2N1bGFyaXph dGlvbiwgUGF0aG9sb2dpYzwva2V5d29yZD48a2V5d29yZD5Qcm90by1PbmNvZ2VuZSBQcm90ZWlu cyBjLWFrdC9tZXRhYm9saXNtPC9rZXl3b3JkPjxrZXl3b3JkPlJOQSBQcm9iZXM8L2tleXdvcmQ+ PGtleXdvcmQ+Uk5BLCBTbWFsbCBJbnRlcmZlcmluZy9waGFybWFjb2xvZ3k8L2tleXdvcmQ+PGtl eXdvcmQ+UmF0czwva2V5d29yZD48a2V5d29yZD5SZWNlcHRvcnMsIEctUHJvdGVpbi1Db3VwbGVk L2FudGFnb25pc3RzICZhbXA7IGluaGliaXRvcnMvZ2VuZXRpY3MvKm1ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+UmVjZXB0b3JzLCBQZXB0aWRlL2dlbmV0aWNzL21ldGFib2xpc208L2tleXdv cmQ+PGtleXdvcmQ+VmFzY3VsYXIgRW5kb3RoZWxpYWwgR3Jvd3RoIEZhY3RvciBBLyptZXRhYm9s aXNtPC9rZXl3b3JkPjwva2V5d29yZHM+PGRhdGVzPjx5ZWFyPjIwMDc8L3llYXI+PHB1Yi1kYXRl cz48ZGF0ZT5TZXA8L2RhdGU+PC9wdWItZGF0ZXM+PC9kYXRlcz48aXNibj4xNTMwLTY4NjAgKEVs ZWN0cm9uaWMpJiN4RDswODkyLTY2MzggKExpbmtpbmcpPC9pc2JuPjxhY2Nlc3Npb24tbnVtPjE3 NDQyNzMwPC9hY2Nlc3Npb24tbnVtPjx1cmxzPjxyZWxhdGVkLXVybHM+PHVybD5odHRwOi8vd3d3 Lm5jYmkubmxtLm5paC5nb3YvZW50cmV6L3F1ZXJ5LmZjZ2k/Y21kPVJldHJpZXZlJmFtcDtkYj1Q dWJNZWQmYW1wO2RvcHQ9Q2l0YXRpb24mYW1wO2xpc3RfdWlkcz0xNzQ0MjczMDwvdXJsPjwvcmVs YXRlZC11cmxzPjwvdXJscz48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+ZmouMDctODExNmNvbSBb cGlpXSYjeEQ7MTAuMTA5Ni9mai4wNy04MTE2Y29tPC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48 bGFuZ3VhZ2U+ZW5nPC9sYW5ndWFnZT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn== ADDIN EN.CITE.DATA (Urayama, et al., 2007)

Table 1.

Involvement of prokineticins in human diseases

4. Conclusion

All together these data showed that PK2 via PKR1 signaling has important roles on heart physiology and pathophysiology. PKR1 is involved in postnatal cardiac vascularization by activating epicardial progenitor cells. These studies also raise numerous questions for further investigation. Do EPDCs differentiate into functional (beating) cardiomyocytes in vitro or in vivo? Do EPDCs differentiate into cardiac lineages in vivo in the damaged adult? Does the activity or potential of EPDCs decline with age? The identification of factors which stimulate endogenous cardiac progenitor cells to induce neovascularization and cardiomyocyte replacement is an evolving paradigm towards therapeutic intervention in cardiac diseases. The race is to facilitate drug discovery for targets acting on cardiomyocytes or EPDCs to invoke new coronary vessels and cardiac tissues as a significant step toward cardioprotection and cardiovascular regeneration.

Acknowledgement

I acknowledge all the members of my laboratory and Dr. Laurent Désaubry for their fruitful discussion during preparation of this article.